10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from________ to ________

Commission File Number 1-32961

CBIZ, Inc.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation

or organization)

6801 Brecksville Rd, Door N, Independence, Ohio

(Address of principal executive offices)

22-2769024

(I.R.S. Employer

Identification No.)

44131

(Zip Code)

(216) 447-9000

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 Par Value	CBZ	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐    No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

Class of Common Stock	Outstanding at October 24, 2022
Common Stock, par value $0.01 per share	50,832,709

CBIZ, INC. AND SUBSIDIARIES

TABLE OF CONTENTS

PART I.	FINANCIAL INFORMATION:		Page
	Item 1.	Condensed Consolidated Financial Statements (Unaudited)	3
		Condensed Consolidated Balance Sheets – September 30, 2022 and December 31, 2021	3
		Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended September 30, 2022 and 2021	4
		Condensed Consolidated Statements of Stockholders’ Equity – Three and Nine Months Ended September 30, 2022 and 2021	5
		Condensed Consolidated Statements of Cash Flows – Nine Months Ended September 30, 2022 and 2021	7
		Notes to the Unaudited Condensed Consolidated Financial Statements	8
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	23
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	39
	Item 4.	Controls and Procedures	39
PART II.	OTHER INFORMATION:
	Item 1.	Legal Proceedings	41
	Item 1A.	Risk Factors	41
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	41
	Item 3.	Defaults Upon Senior Securities	41
	Item 4.	Mine Safety Disclosures	42
	Item 5.	Other Information	42
	Item 6.	Exhibits	43
	Signature		44

2

PART I – FINANCIAL INFORMATION

Item 1.    Financial Statements

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In thousands)

	September 30, 2022		December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents	$	2,040	$	1,997
Restricted cash	39,555		30,383
Accounts receivable, net	398,970		242,168
Other current assets	17,065		19,217
Current assets before funds held for clients	457,630		293,765
Funds held for clients	125,451		157,909
Total current assets	583,081		451,674
Non-current assets:
Property and equipment, net	45,469		43,423
Goodwill and other intangible assets, net	957,186		840,783
Assets of deferred compensation plan	111,060		136,321
Operating lease right-of-use assets, net	191,699		151,145
Other non-current assets	11,123		4,588
Total non-current assets	1,316,537		1,176,260
Total assets	$	1,899,618	$	1,627,934
LIABILITIES
Current liabilities:
Accounts payable	$	74,247	$	65,757
Income taxes payable	14,037		1,671
Accrued personnel costs	125,310		114,032
Contingent purchase price liabilities	61,355		34,373
Operating lease liabilities	36,519		30,586
Other current liabilities	19,045		18,755
Current liabilities before client fund obligations	330,513		265,174
Client fund obligations	128,091		158,115
Total current liabilities	458,604		423,289
Non-current liabilities:
Bank debt	271,100		155,300
Debt issuance costs	(2,164)		(449)
Total long-term debt, net	268,936		154,851
Income taxes payable	2,069		1,727
Deferred income taxes, net	22,566		15,440
Deferred compensation plan obligations	111,060		136,321
Contingent purchase price liabilities	79,853		44,766
Operating lease liabilities	181,841		145,808
Other non-current liabilities	564		1,184
Total non-current liabilities	666,889		500,097
Total liabilities	1,125,493		923,386
STOCKHOLDERS' EQUITY
Common stock	1,361		1,352
Additional paid in capital	793,514		770,117
Retained earnings	745,614		628,762
Treasury stock	(769,981)		(694,716)
Accumulated other comprehensive income (loss)	3,617		(967)
Total stockholders’ equity	774,125		704,548
Total liabilities and stockholders’ equity	$	1,899,618	$	1,627,934

See the accompanying notes to the unaudited condensed consolidated financial statements

3

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In thousands, except per share data)

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Revenue	$	363,262	$	282,719	$	1,116,936	$	862,097
Operating expenses	306,017		238,328		886,052		699,233
Gross margin	57,245		44,391		230,884		162,864
Corporate general and administrative expenses	15,893		13,035		43,128		41,334
Legal settlement, net	—		—		—		30,468
Operating income	41,352		31,356		187,756		91,062
Other income (expense):
Interest expense	(2,305)		(1,016)		(5,209)		(2,852)
Gain on sale of operations, net	176		—		311		6,385
Other (expense) income, net	(2,618)		(1,133)		(24,919)		12,029
Total other (expense) income, net	(4,747)		(2,149)		(29,817)		15,562
Income from continuing operations before income tax expense	36,605		29,207		157,939		106,624
Income tax expense	9,131		7,512		41,074		26,100
Income from continuing operations	27,474		21,695		116,865		80,524
Loss from discontinued operations, net of tax	(4)		(4)		(13)		(17)
Net income	$	27,470	$	21,691	$	116,852	$	80,507
Earnings per share:
Basic:
Continuing operations	$	0.53	$	0.41	$	2.25	$	1.52
Discontinued operations	—		—		—		—
Net income	$	0.53	$	0.41	$	2.25	$	1.52
Diluted:
Continuing operations	$	0.53	$	0.41	$	2.22	$	1.50
Discontinued operations	—		—		—		—
Net income	$	0.53	$	0.41	$	2.22	$	1.50
Basic weighted average shares outstanding	51,457		52,425		51,827		52,885
Diluted weighted average shares outstanding	52,238		53,226		52,720		53,796
Comprehensive income:
Net income	$	27,470	$	21,691	$	116,852	$	80,507
Other comprehensive income, net of tax	2,179		159		4,584		1,071
Comprehensive income	$	29,649	$	21,850	$	121,436	$	81,578

See the accompanying notes to the unaudited condensed consolidated financial statements

4

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(In thousands)

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive  Income (Loss)		Totals
June 30, 2022	135,823	84,221	$	1,358	$	781,142	$	718,144	$	(737,559)	$	1,438	$	764,523
Net income	—	—	—		—		27,470		—		—		27,470
Other comprehensive income	—	—	—		—		—		—		2,179		2,179
Share repurchases	—	744	—		—		—		(32,422)		—		(32,422)
Restricted stock units and awards	1	—	—		—		—		—		—		—
Stock options exercised	254	—	2		4,096		—		—		—		4,098
Stock-based compensation	—	—	—		5,559		—		—		—		5,559
Business acquisitions	68	—	1		2,717		—		—		—		2,718
September 30, 2022	136,146	84,965	$	1,361	$	793,514	$	745,614	$	(769,981)	$	3,617	$	774,125

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Totals
June 30, 2021	134,892	82,173	$	1,349	$	757,421	$	616,691	$	(661,772)	$	(1,357)	$	712,332
Net income	—	—	—		—		21,691		—		—		21,691
Other comprehensive income	—	—	—		—		—		—		159		159
Share repurchases	—	650	—		—		—		(21,445)		—		(21,445)
Stock options exercised	142	—	1		1,694		—		—		—		1,695
Stock-based compensation	—	—	—		2,905		—		—		—		2,905
Business acquisitions	99	—	1		3,309		—		—		—		3,310
September 30, 2021	135,133	82,823	$	1,351	$	765,329	$	638,382	$	(683,217)	$	(1,198)	$	720,647

5

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(In thousands)

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Totals
December 31, 2021	135,187	83,149	$	1,352	$	770,117	$	628,762	$	(694,716)	$	(967)	$	704,548
Net income	—	—	—		—		116,852		—		—		116,852
Other comprehensive income	—	—	—		—		—		—		4,584		4,584
Share repurchases	—	1,628	—		—		—		(67,976)		—		(67,976)
Indirect repurchase of shares for minimum tax withholding	—	188	—		—		—		(7,289)		—		(7,289)
Restricted stock units and awards	120	—	1		(1)		—		—		—		—
Performance share units	211	—	2		(2)		—		—		—		—
Stock options exercised	541	—	5		7,989		—		—		—		7,994
Stock-based compensation	—	—	—		11,987		—		—		—		11,987
Business acquisitions	87	—	1		3,424		—		—		—		3,425
September 30, 2022	136,146	84,965	$	1,361	$	793,514	$	745,614	$	(769,981)	$	3,617	$	774,125

	Issued Common Shares	Treasury Shares	Common Stock		Additional Paid-In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Totals
December 31, 2020	134,144	80,045	$	1,341	$	740,970	$	557,875	$	(595,297)	$	(2,269)	$	702,620
Net income	—	—	—		—		80,507		—		—		80,507
Other comprehensive income	—	—	—		—		—		—		1,071		1,071
Share repurchases	—	2,686	—		—		—		(84,883)		—		(84,883)
Indirect repurchase of shares for minimum tax withholding	—	92	—		—		—		(3,037)		—		(3,037)
Restricted stock units and awards	80	—	1		(1)		—		—		—		—
Stock options exercised	635	—	6		7,137		—		—		—		7,143
Stock-based compensation	—	—	—		8,359		—		—		—		8,359
Business acquisitions	274	—	3		8,864		—		—		—		8,867
September 30, 2021	135,133	82,823	$	1,351	$	765,329	$	638,382	$	(683,217)	$	(1,198)	$	720,647

See the accompanying notes to the unaudited condensed consolidated financial statements

6

CBIZ, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In thousands)

	Nine Months Ended September 30,
	2022		2021
Cash flows from operating activities:
Net income	$	116,852	$	80,507
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	24,707		19,921
Gain on sale of operations, net	(311)		(6,385)
Bad debt expense, net of recoveries	1,295		562
Adjustment to contingent earnout liability	1,917		1,599
Stock-based compensation expense	11,987		8,359
Deferred income taxes	5,690		7,141
Other, net	(2,083)		(373)
Changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable, net	(125,700)		(66,017)
Other assets	(2,610)		53
Accounts payable	6,203		12,126
Income taxes payable	12,709		5,245
Accrued personnel costs	18,863		15,329
Other liabilities	(9,447)		2,897
Operating cash flows provided by continuing operations	60,072		80,964
Operating cash flows used in discontinued operations	(13)		(18)
Net cash provided by operating activities	60,059		80,946
Cash flows from investing activities:
Business acquisitions and purchases of client lists, net of cash acquired	(79,289)		(66,155)
Purchases of client fund investments	(19,771)		(13,050)
Proceeds from the sales and maturities of client fund investments	11,500		10,800
Proceeds from sales of divested operations	2,906		9,785
Change in funds held for clients	(171)		(5,708)
Additions to property and equipment	(6,030)		(6,451)
Other, net	(4,695)		51
Net cash used in investing activities	(95,550)		(70,728)
Cash flows from financing activities:
Proceeds from bank debt	655,500		680,400
Payment of bank debt	(539,700)		(598,200)
Payment for acquisition of treasury stock	(65,976)		(84,950)
Indirect repurchase of shares for minimum tax withholding	(7,289)		(3,037)
Changes in client funds obligations	(30,024)		8,375
Proceeds from exercise of stock options	7,994		7,143
Payment of contingent consideration for acquisitions	(12,408)		(7,883)
Other, net	(2,072)		(170)
Net cash provided by financing activities	6,025		1,678
Net (decrease) increase in cash, cash equivalents and restricted cash	(29,466)		11,896
Cash, cash equivalents and restricted cash at beginning of year	150,474		170,335
Cash, cash equivalents and restricted cash at end of period	$	121,008	$	182,231
Reconciliation of cash, cash equivalents and restricted cash to the   Condensed Consolidated Balance Sheets:
Cash and cash equivalents	$	2,040	$	2,749
Restricted cash	39,555		37,320
Cash equivalents included in funds held for clients	79,413		142,162
Total cash, cash equivalents and restricted cash	$	121,008	$	182,231

See the accompanying notes to the unaudited condensed consolidated financial statements

7

CBIZ, INC. AND SUBSIDIARIES

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Selected Terms Used in Notes to the Condensed Consolidated Financial Statements

ASA – Administrative Service Agreement

ASC – Accounting Standards Codification

ASU – Accounting Standards Update

CPA firm – Certified Public Accounting firm

FASB – The Financial Accounting Standards Board

GAAP – United States Generally Accepted Accounting Principles

SOFR – Secured Overnight Financing Rate

LIBOR – London Interbank Offered Rate

SEC – United States Securities and Exchange Commission

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements: The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2022.

Use of Estimates: The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In 2021, CBIZ formed a grantor trust (the “Trust”) with Wilmington Savings Funds Society, FSB, a Federal savings bank, serving as trustee. The Trust holds the majority of the funds provided by CBIZ’s clients for payroll processing pending remittance to employees of those clients, tax authorities, and

8

other payees. CBIZ is the sole beneficial owner of the Trust. The Trust is considered a variable interest entity in accordance with Accounting Standards Codification 810, Consolidation. CBIZ has both the power to direct the activities that most significantly impact the economic performance of the Trust (including the power to make all investment decisions for the Trust) and the right to receive benefits that could potentially be significant to the Trust (in the form of investment returns). As a result, CBIZ consolidates the Trust in its unaudited condensed consolidated financial statements.

NOTE 2. NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Adopted in 2022

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship.

On May 4, 2022, we entered into a Second Amended and Restated Credit Agreement (the "2022 credit facility" or the "credit facility"), by and among CBIZ Operations, Inc. ("CBIZ Operations"), and Bank of America, N.A., as administrative agent, and other financial institutions. The 2022 credit facility amends the Amended and Restated Credit Agreement, dated as of April 3, 2018 (the "2018 credit facility"). Among other things, the 2022 Credit Facility amended the base interest rate from LIBOR to Term SOFR. Consequently, we amended the interest rate swap agreements with respect to the existing swaps. Effective May 16, 2022, the scheduled reset date, the interest rate of the swaps were set to one-month Term SOFR to align the swaps to Term SOFR in the 2022 credit facility. No other terms under the swap agreements were amended. As a result, we early adopted ASC Topic 848, Reference Rate Reform. This adoption had immaterial impact on our consolidated financial statements. Refer to Note 4, Debt and Financing Arrangements and Note 6, Financial Instruments, for further discussion of the transaction.

NOTE 3. ACCOUNTS RECEIVABLE, NET

Accounts receivable, less allowance for doubtful accounts, reflects the net realizable value of receivables and approximates fair value. Unbilled revenue is recorded at estimated net realizable value. Assessing the collectability of the receivables (billed and unbilled) requires management judgment based on a combination of factors, including but not limited to, an evaluation of our historical incurred loss experience, credit-worthiness of our clients, age of the trade receivable balance, current economic

9

conditions that may affect a client’s ability to pay, and reasonable and supportable forecasts. Receivables are charged-off against the allowance when the balance is deemed uncollectible.

Accounts receivable, net, at September 30, 2022 and December 31, 2021 was as follows (in thousands):

	September 30, 2022		December 31, 2021
Trade accounts receivable	$	252,251	$	190,710
Unbilled revenue, at net realizable value	167,083		67,616
Total accounts receivable	419,334		258,326
Allowance for doubtful accounts	(20,364)		(16,158)
Accounts receivable, net	$	398,970	$	242,168

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2022 and twelve months ended December 31, 2021 are as follows (in thousands):

	September 30, 2022		December 31, 2021
Balance at beginning of period	$	(16,158)	$	(14,894)
Provision	(9,796)		(9,422)
Charge-offs, net of recoveries	5,590		8,158
Allowance for doubtful accounts	$	(20,364)	$	(16,158)

NOTE 4. DEBT AND FINANCING ARRANGEMENTS

On May 4, 2022, we entered into the 2022 credit facility, which amends the 2018 credit facility.

The 2022 credit facility increased our borrowing capacity from $400 million to $600 million, which provides us with the capital necessary to meet our working capital needs as well as the flexibility to continue with our strategic initiatives, including business acquisitions and share repurchases. Other important key terms of the 2022 credit facility include: (i) an accordion feature that permits lenders to extend an additional $200 million at later date; (ii) no change in pricing from the 2018 credit facility; (iii) upsizing of baskets and various sublimits to reflect the increased size of the Company's business; (iv) a swing line facility increase from $25 million to $50 million, which provides for same-day funds to cover daily liquidity needs; and (v) base interest rate amended from LIBOR to Term SOFR. The 2022 credit facility extends the maturity date from 2023 to 2027.

In connection with our 2022 credit facility, we incurred approximately $2.1 million of financing costs during the second quarter of 2022. The financing costs are deferred and reported as a reduction of debt on the accompanying unaudited Condensed Consolidated Balance Sheets, are included as a component of cash flow from financing activities on the accompanying unaudited Condensed Consolidated Statements of Cash Flows, and are being amortized as interest expense over the term of the 2022 credit facility. In addition, we wrote-off approximately $41 thousand of unamortized deferred cost associated with the 2018 credit facility as additional interest expense in the second quarter of 2022.

The balance outstanding under the 2022 credit facility was $271.1 million at September 30, 2022. The balance outstanding under the 2018 credit facility was $155.3 million at December 31, 2021. The combined effective interest rates under the 2018 and 2022 credit facilities, including the impact of interest rate swaps associated with those credit facilities, were as follows:

	Nine Months Ended September 30,
	2022	2021
Weighted average rates	2.29%	1.89%
Range of effective rates	1.08% - 4.18%	1.06% - 3.64%

10

We had approximately $310.9 million of available funds under the 2022 credit facility at September 30, 2022, net of outstanding letters of credit of $5.7 million. Available funds under the credit facility are based on a multiple of earnings before interest, taxes, depreciation and amortization as defined in the credit facility, and are reduced by letters of credit, other indebtedness and outstanding borrowings under the credit facility. Under the 2022 credit facility, loans are charged an interest rate consisting of a base rate or Term SOFR rate plus an applicable margin, letters of credit are charged based on the same applicable margin, and a commitment fee is charged on the unused portion of the credit facility.

The 2022 credit facility contains certain restrictive covenants customary for facilities of this type, including restrictions on indebtedness, liens or other encumbrances, making certain payments, investments, or to sell or otherwise dispose of a substantial portion of assets, or to merge or consolidate with an unaffiliated entity. The 2022 credit facility also limits our ability to make dividend payments. Historically, we have not paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. Our Board of Directors has discretion over the payment and level of dividends on common stock, subject to the limitations of the credit facility and applicable law. The credit facility contains a provision that, in the event of a defined change in control, the credit facility may be terminated. In addition, the 2022 credit facility contains financial covenants that require us to meet certain requirements with respect to (i) a total leverage ratio and (ii) minimum interest coverage ratio which may limit our ability to borrow up to the total commitment amount. As of September 30, 2022, we are in compliance with all covenants.

Other Line of Credit - We have an unsecured $20.0 million line of credit by and among CBIZ Benefits and Insurance, Inc. and Huntington National Bank. We utilize this line to support our short-term funding requirements of payroll client fund obligations due to the investment of client funds, rather than liquidating client funds that have already been invested in available-for-sale securities. The line of credit, which was renewed on August 1, 2022 and will terminate on August 3, 2023, did not have a balance outstanding at September 30, 2022.

Interest Expense - Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2022		2021
Credit facilities	$	2,301	$	1,010
Other line of credit	4		—
Other	—		6
Total	$	2,305	$	1,016

	Nine Months Ended September 30,
	2022		2021
Credit facilities	$	5,204	$	2,833
Other line of credit	5		—
Other	—		19
Total	$	5,209	$	2,852

NOTE 5. COMMITMENTS AND CONTINGENCIES

Letters of Credit and Guarantees - We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $5.7 million and $3.4 million at September 30, 2022 and December 31, 2021, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.3 million at September 30, 2022 and December 31, 2021, respectively.

Legal Proceedings - On December 19, 2016, CBIZ Operations was named as a defendant in a lawsuit filed by Zotec Partners, LLC (“Zotec”) in the Marion County Indiana Superior Court. After various amendments, the lawsuit asserts claims under Indiana law for securities, statutory and common law fraud or deception, unjust enrichment, breach of contract, and vicarious liability against CBIZ Operations and a former employee of CBIZ MMP in connection with the sale of the CBIZ MMP medical billing practice to Zotec. The plaintiff claims that CBIZ Operations had a duty to disclose the fact,

11

unknown to employees of CBIZ Operations at the time of the transaction, that the former employee had a financial arrangement with a Zotec vendor at the time CBIZ Operations sold CBIZ MMP to Zotec. The plaintiff is seeking damages of up to $177.0 million out of the $200.0 million transaction price. Trial was held in October 2021. The jury found in favor of CBIZ on all fraud, contract and other claims before it. Zotec’s remaining claim for Indiana statutory securities fraud and CBIZ’s counterclaim for breach of contract against Zotec will be addressed by the trial Judge at a later date.

In addition to the item disclosed above, the Company is, from time to time, subject to claims and lawsuits arising in the ordinary course of business. We cannot predict the outcome of all such matters or estimate the possible loss, if any. Although the proceedings are subject to uncertainties in the litigation process and the ultimate disposition of these proceedings is not presently determinable, we intend to vigorously defend these matters.

NOTE 6. FINANCIAL INSTRUMENTS

Available-For-Sale Debt Securities - In connection with certain services provided by our payroll operations, we collect funds from our clients’ accounts in advance of paying client obligations. These funds held for clients are segregated and invested in accordance with our investment policy, which requires all investments carry an investment grade rating at the time of initial investment. These investments, primarily consisting of corporate and municipal bonds, are classified as available-for-sale and are included in the “Funds held for clients” line item on the accompanying unaudited Condensed Consolidated Balance Sheets. The par value of these investments totaled $45.3 million and $37.0 million at September 30, 2022 and December 31, 2021, respectively, and had maturity or callable dates ranging from October 2022 through November 2025.

At September 30, 2022, unrealized losses on the securities were not material and have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.

The following table summarizes activities related to these investments for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021 (in thousands):

	Nine Months Ended September 30, 2022		Twelve Months Ended December 31, 2021
Fair value at beginning of period	$	38,670	$	25,708
Purchases	19,771		26,980
Redemptions	(5,630)		(6,530)
Maturities	(5,870)		(8,347)
Change in bond premium	(350)		1,517
Fair market value adjustment	(2,218)		(658)
Fair value at end of period	$	44,373	$	38,670

In addition to the available-for-sale debt securities discussed above, we also held other depository assets in the amount of $1.7 million and $1.1 million at September 30, 2022 and December 31, 2021, respectively. Those depository assets are classified as Level 1 in the fair value hierarchy.

Interest Rate Swaps - We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under our credit facility, or the forecasted acquisition of such liability. We do not purchase or hold any derivative instruments for trading or speculative purposes. Refer to the Annual Report on Form 10-K for the year ended December 31, 2021 for further discussion on our interest rate swaps.

As a result of the 2022 credit facility, CBIZ amended the interest rate swap agreements with respect to the existing swaps. Effective May 16, 2022, the scheduled reset date, the interest rate of the swaps are set to one-month Term SOFR to align the swaps to Term SOFR in the 2022 credit facility as a result of reference rate reform. No other terms under the swap agreements were amended.

During the third quarter of 2022, we entered into a new 5-year interest rate swap with a notional value of $20 million and fixed rate of 2.45%

12

Under the terms of the interest rate swaps, we pay interest at a fixed rate of interest plus applicable margin as stated in the amended agreements, and receive interest that varies with the one-month Term SOFR.

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying unaudited Condensed Consolidated Balance Sheets at September 30, 2022 and December 31, 2021 (amounts in thousands):

	September 30, 2022
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	15,000	2.571	%	6/1/2023	$	130	Other current asset
Interest rate swap	$	50,000	0.834	%	4/14/2025	$	3,820	Other non-current asset
Interest rate swap	$	30,000	1.186	%	12/14/2026	$	3,020	Other non-current asset
Interest rate swap	$	20,000	2.450	%	8/14/2027	$	1,147	Other non-current asset

	December 31, 2021
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	1.770	%	5/14/2022	$	(120)	Other current liability
Interest rate swap	$	15,000	2.640	%	6/1/2023	$	(432)	Other non-current liability
Interest rate swap	$	50,000	0.885	%	4/14/2025	$	405	Other non-current asset
Interest rate swap	$	30,000	1.249	%	12/14/2026	$	(64)	Other non-current liability

Refer to Note 7, Fair Value Measurements, for additional disclosures regarding fair value measurements.

The following table summarizes the effects of the interest rate swaps on the accompanying unaudited Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Gain Recognized in AOCI, net of tax				Gain (Loss) Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	2,815	$	66	$	220	$	(285)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	6,009	$	718	$	(278)	$	(850)

NOTE 7. FAIR VALUE MEASUREMENTS

The following table summarizes our assets and (liabilities) at September 30, 2022 and December 31, 2021, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2022		December 31, 2021
Deferred compensation plan assets	1	$	111,060	$	136,321
Available-for-sale debt securities	1	44,373		38,670
Other depository assets	1	1,665		1,144
Deferred compensation plan liabilities	1	(111,060)		(136,321)
Interest rate swaps	2	8,117		(211)
Contingent purchase price liabilities	3	(141,208)		(79,139)

During the nine months ended September 30, 2022 and 2021, there were no transfers between the valuation hierarchy Levels 1, 2 and 3. The following table summarizes the change in Level 3 fair values

13

of our contingent purchase price liabilities for the nine months ended September 30, 2022 and 2021 (pre-tax basis) (in thousands):

	2022		2021
Beginning balance – January 1	$	(79,139)	$	(54,391)
Additions from business acquisitions	(74,199)		(38,149)
Settlement of contingent purchase price liabilities	14,047		9,511
Change in fair value of contingencies	461		(336)
Change in net present value of contingencies	(2,378)		(1,263)
Ending balance – September 30	$	(141,208)	$	(84,628)

Contingent purchase price liabilities result from our business acquisitions and are recorded at fair value at the time of acquisition and are presented as “Contingent purchase price liabilities — current” and “Contingent purchase price liabilities — non-current” in the accompanying unaudited Condensed Consolidated Balance Sheets. We estimate the fair value of our contingent purchase price liabilities using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value.

We probability weight risk-adjusted estimates of future performance of acquired businesses, then calculate the contingent purchase price based on the estimates and discount them to present value representing management’s best estimate of fair value. The fair value of the contingent purchase price liabilities is reassessed quarterly based on assumptions provided by practice group leaders and business unit controllers together with our corporate finance department. Any change in the fair value estimate is recorded in the earnings of that period. Refer to Note 11, Business Combinations, for further discussion of our acquisitions and contingent purchase price liabilities.

The carrying amounts of our cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short maturity of these instruments, and the carrying value of bank debt approximates fair value as the interest rate on the bank debt is variable and approximates current market rates. As a result, the fair value measurement of our bank debt is considered to be Level 2 under the fair value hierarchy.

NOTE 8. OTHER COMPREHENSIVE INCOME

The following table is a summary of other comprehensive income and discloses the tax impact of each component of other comprehensive income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(457)	$	(116)	$	(1,614)	$	(274)
Net unrealized gain on interest rate swaps, net of income taxes (2)	2,647		281		6,218		1,359
Foreign currency translation	(11)		(6)		(20)		(14)
Total other comprehensive income	$	2,179	$	159	$	4,584	$	1,071

(1)Net of income tax benefit of $171 and income tax benefit of $44 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax benefit of $604 and income tax benefit of $103 for the nine months ended September 30, 2022 and 2021, respectively.

(2)Net of income tax expense of $863 and income tax expense of $90 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax expense of $2,041 and income tax expense of $436 for the nine months ended September 30, 2022 and 2021, respectively.

14

NOTE 9. EMPLOYEE STOCK PLANS

The 2019 Stock Omnibus Incentive Plan (the “2019 Plan”), which expires in 2029, permits the grant of various forms of stock-based awards. The terms and vesting schedules for the stock-based awards vary by type and date of grant. A maximum of 3.1 million stock options, restricted stock or other stock-based compensation awards may be granted. Shares subject to award under the 2019 Plan may be either authorized but unissued shares of our common stock or treasury shares. Refer to the Annual Report on Form 10-K for the year ended December 31, 2021 for further discussion on the 2019 Plan.

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Stock options	$	—	$	581	$	248	$	1,114
Restricted stock units and awards	1,188		1,388		4,015		4,214
Performance share units	4,371		936		7,724		3,031
Total stock-based compensation expense	$	5,559	$	2,905	$	11,987	$	8,359

Stock Options and Restricted Stock Units and Awards – The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2022 (in thousands, except per share data):

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,223	$	17.71	389	$	25.07
Granted	—	$	—	130	$	38.53
Exercised or released	(541)	$	14.78	(238)	$	23.47
Expired or canceled	—	$	—	(4)	$	34.04
Outstanding at September 30, 2022	682	$	20.04	277	$	32.62
Exercisable at September 30, 2022	682	$	20.04

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

Performance Share Units (“PSUs”) – PSUs are earned based on our financial performance over a contractual term of three years and the associated expense is recognized over that period based on the fair value of the award. A three-year cliff vesting schedule of the PSUs is dependent upon the Company’s performance relative to pre-established goals based on an earnings per share target (weighted 70%) and total growth in revenue (weighted 30%). The fair value of PSUs is calculated using the market value of a share of our common stock on the date of grant. For performance achieved above specified levels, the recipient may earn additional shares of stock, not to exceed 200% of the number of PSUs initially granted.

The following table presents our PSU award activity during the nine months ended September 30, 2022 (in thousands, except per share data):

15

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	473	$	23.64
Granted	103	$	38.15
Vested	(211)	$	19.82
Adjustments for performance results (2)	82	$	25.75
Canceled	(5)	$	33.21
Outstanding at September 30, 2022	442	$	29.12

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

(2)Represents the change in the number of performance awards earned based on performance achievement for the performance period.

NOTE 10. EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Income from continuing operations	$	27,474	$	21,695	$	116,865	$	80,524
Denominator:
Basic
Weighted average common shares outstanding	51,457		52,425		51,827		52,885
Diluted
Stock options (1)	434		609		523		692
Restricted stock units and awards (1)	118		155		141		182
Performance share units	205		—		205		—
Contingent shares (2)	24		37		24		37
Diluted weighted average common shares    outstanding (3)	52,238		53,226		52,720		53,796
Basic earnings per share from continuing operations	$	0.53	$	0.41	$	2.25	$	1.52
Diluted earnings per share from continuing operations	$	0.53	$	0.41	$	2.22	$	1.50

(1)A total of 72 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the nine months ended September 30, 2022, as their effect would be anti-dilutive. No stock-based awards were exclude from the calculation of diluted earnings per share for the three months ended September 30, 2022, as their effect was dilutive. A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 237 thousand performance share units for both the three and nine months ended September 30, 2022, and the denominator used in calculating diluted earnings per share did not include 447 thousand

16

performance share units for both the three and nine months ended September 30, 2021. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2022 and 2021.

NOTE 11. BUSINESS COMBINATIONS

Business Combinations

During the nine months ended September 30, 2022, we completed the following acquisitions:

•Effective January 1, 2022, we acquired all of the non-attest assets of Marks Paneth LLP ("Marks Paneth"). Marks Paneth, based in New York City, is a provider of a full range of accounting, tax and consulting services to a wide range of industries. Marks Paneth is included as a component of our Financial Services practice group. Operating results are reported in the Financial Services practice group.

•Effective July 1, 2022, we acquired substantially all the assets of Stinnett & Associates, LLC ("Stinnett"). Stinnett, located in Tulsa, Oklahoma, is a professional advisory firm and certified Women's Business Enterprise providing internal audit, Sarbanes-Oxley compliance, cybersecurity reviews, business continuity and disaster recovery, and fraud investigations to businesses of all sizes including Fortune 1000 organizations in a variety of industries. Operating results are reported in the Financial Services practice group.

During the nine months ended September 30, 2021, we completed the following acquisitions:

•Effective January 1, 2021, we acquired substantially all the assets of Middle Market Advisory Group (“MMA”). MMA, based in Englewood, Colorado, is a provider of tax compliance and consulting services to middle market companies and family groups in the real estate, automotive, technology and SAAS, construction, and manufacturing industries. Operating results are reported in the Financial Services practice group.

•Effective April 1, 2021, we acquired substantially all the assets of Wright Retirement Services, LLC ("Wright"). Wright, located in Valdosta, Georgia, specializes in third party administration services for retirement plan sponsors. Operating results are reported in the Benefits and Insurance practice group.

•Effective May 1, 2021, we acquired substantially all of the non-attest assets of Berntson Porter & Company, PLLC ("BP"). BP, based in Bellevue, Washington is a provider of comprehensive accounting and financial consulting services including tax, forensic, economic and valuation services and transaction services to a wide range of industries with specialties including construction, real estate, hospitality, manufacturing and technology. Operating results are reported in the Financial Services practice group.

•Effective June 1, 2021, we acquired all of the issued and outstanding membership interests of Schramm Health Partners, LLC dba Optumas ("Optumas"). Optumas, based in Scottsdale, Arizona, is a provider of actuarial services to state government health care agencies to assist in the administration of Medicaid programs. Operating results are reported in the Financial Services practice group.

•Effective September 1, 2021, we acquired all of the non-attest assets of Shea Labagh Dobberstein ("SLD"). SLD, based in San Francisco, California, is a provider of professional accounting, tax and advisory services to privately held businesses, individuals and nonprofit organizations. Operating results are reported in the Financial Services practice group.

The acquisitions of Marks Paneth and Stinnett are expected to add approximately $154.5 million annualized revenue in 2022. For the nine months ended September 30, 2022, we recorded approximately $9.3 million in non-recurring transaction, retention and integration related costs associated with the Marks Paneth acquisition. Pro forma results of operations for these acquisitions have not been presented because the effects of these acquisitions were not material, either individually or in aggregate, to our total revenue, income from continuing operations, and net income for the three and nine months ended September 30, 2022 and 2021, respectively.

17

The following table summarizes the consideration and purchase price allocation for the acquisitions completed during the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	2022		2021
Common stock issued (number)	42		207
Common stock value	$	1,668	$	6,940
Cash paid	79,141		66,051
Recorded contingent consideration	74,199		38,148
Total recorded purchase price	$	155,008	$	111,139
Accounts receivable acquired	20,429		13,125
Fixed assets acquired	1,933		1,473
Identifiable intangible assets acquired	53,400		40,753
Operating lease right-of-use asset acquired	49,291		17,814
Other assets acquired	1,693		1,316
Operating lease liability acquired - current	(5,860)		(2,785)
Other current liabilities acquired	(1,594)		(5,735)
Operating lease liability acquired - non-current	(43,431)		(15,029)
Goodwill	79,147		60,207
Total net assets acquired	$	155,008	$	111,139
Maximum potential contingent consideration	$	77,075	$	40,126

The following table summarizes the goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Nine Months Ended September 30,
	2022				2021
	Financial Services		Benefits and Insurance Services		Financial Services		Benefits and Insurance Services
Goodwill	$	79,147	$	—	$	58,409	$	1,798
Client list	53,400		—		38,580		1,290
Other intangibles	—		—		837		46
Total	$	132,547	$	—	$	97,826	$	3,134

Goodwill is calculated as the difference between the aggregated purchase price and the fair value of the net assets acquired. Goodwill represents the value of expected future earnings and cash flows, as well as the synergies created by the integration of the new businesses within our organization, including cross-selling opportunities expected with our Financial Services practice group and the Benefits and Insurance Services practice group, to help strengthen our existing service offerings and expand our market position. Goodwill related to these acquisitions is deductible for tax purposes. Client lists from the aforementioned acquisitions have an expected life up to 10 years, and other intangibles, primarily non-compete agreements, have an expected life of 3 years. Client lists and non-compete agreements are valued using a discounted cash flow technique based on management estimates of future cash flows from such assets.

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and contingent payments made for previous business acquisitions in the three and nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net expense	$	440	$	846	$	1,917	$	1,599
Cash settlement paid	$	4,167	$	—	$	12,289	$	7,584
Shares issued (number)	26		13		45		66

Divestitures

18

Divested operations and assets that do not qualify for treatment as discontinued operations are recorded as “Gain on sale of operations, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. During the nine months ended September 30, 2021, we sold one business unit for $9.7 million in the Benefit and Insurance practice group and recorded a gain of $6.4 million.

In addition, during the three and nine months ended September 30, 2022, we sold one small book of business for $2.5 million in the Benefits and Insurance Services practice group and recorded a gain of $2.4 million. This gain is recorded as “Other (expense) income, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. Gain on book of business sales in the three and nine months ended September 30, 2021 was immaterial.

NOTE 12. SEGMENT DISCLOSURES

Our business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services and National Practices. The business units have been aggregated based on the following factors: similarity of the products and services provided to clients; similarity of the regulatory environment in which they operate; and similarity of economic conditions affecting long-term performance. The business units are managed along these segment lines. A general description of services provided by each practice group is provided in the table below.

Financial Services	Benefits and Insurance Services	National Practices
Accounting and Tax	Employee Benefits Consulting	Information Technology Managed Networking and Hardware Services
Financial Advisory	Payroll / Human Capital Management	Healthcare Consulting
Valuation	Property and Casualty Insurance
Risk and Advisory Services	Retirement and Investment Services
Government Healthcare Consulting

Corporate and Other - Included in Corporate and Other are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

Accounting policies of the practice groups are the same as those described in Note 1, Basis of Presentation and Significant Accounting Policies, to the Annual Report on Form 10-K for the year ended December 31, 2021. Upon consolidation, intercompany accounts and transactions are eliminated, thus inter-segment revenue is not included in the measure of profit or loss for the practice groups. Performance of the practice groups is evaluated on income (loss) from continuing operations before income tax expense (benefit) excluding those costs listed above, which are reported in the “Corporate and Other”.

Segment information for the three and nine months ended September 30, 2022 and 2021 is presented below. We do not manage our assets on a segment basis, therefore segment assets are not presented below.

The following table disaggregates our revenue by source (in thousands):

19

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	259,998	—		—		$	259,998
Core benefits and insurance services	—		88,364		—		88,364
Non-core benefits and insurance services	—		3,703		—		3,703
Managed networking, hardware services	—		—		8,514		8,514
National practices consulting	—		—		2,683		2,683
Total revenue	$	259,998	$	92,067	$	11,197	$	363,262

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	808,052	—		—		$	808,052
Core benefits and insurance services	—		264,666		—		264,666
Non-core benefits and insurance services	—		11,595		—		11,595
Managed networking, hardware services	—		—		24,768		24,768
National practices consulting	—		—		7,855		7,855
Total revenue	$	808,052	$	276,261	$	32,623	$	1,116,936

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

20

Segment information for the three months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	259,998	$	92,067	$	11,197	$	—	$	363,262
Operating expenses	220,337		73,321		9,743		2,616		306,017
Gross margin	39,661		18,746		1,454		(2,616)		57,245
Corporate general and administrative expenses	—		—		—		15,893		15,893
Operating income (loss)	39,661		18,746		1,454		(18,509)		41,352
Other income (expense):
Interest expense	—		(4)		—		(2,301)		(2,305)
Gain on sale of operations, net	176		—		—		—		176
Other income (expense), net	103		2,402		8		(5,131)		(2,618)
Total other income (expense), net	279		2,398		8		(7,432)		(4,747)
Income (loss) from continuing operations before income tax expense	$	39,940	$	21,144	$	1,462	$	(25,941)	$	36,605

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

21

Segment information for the nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	808,052	$	276,261	$	32,623	$	—	$	1,116,936
Operating expenses (income)	639,780		220,998		29,218		(3,944)		886,052
Gross margin	168,272		55,263		3,405		3,944		230,884
Corporate general and administrative expenses	—		—		—		43,128		43,128
Operating income (loss)	168,272		55,263		3,405		(39,184)		187,756
Other income (expense):
Interest expense	—		(5)		—		(5,204)		(5,209)
Gain on sale of operations, net	311		—		—		—		311
Other income (expense), net	274		2,366		9		(27,568)		(24,919)
Total other income (expense), net	585		2,361		9		(32,772)		(29,817)
Income (loss) from continuing operations before income tax expense	$	168,857	$	57,624	$	3,414	$	(71,956)	$	157,939

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net	—		—		—		30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

NOTE 13. SUBSEQUENT EVENTS

Subsequent to September 30, 2022 and up to October 26, 2022, we repurchased approximately 0.4 million shares of our common stock in the open market at a total cost of approximately $18.0 million.

22

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to “we”, “us”, “our”, "CBIZ" or the "Company" shall mean CBIZ, Inc., a Delaware corporation, and its operating subsidiaries.

The following discussion is intended to assist in the understanding of our financial position at September 30, 2022 and December 31, 2021, results of operations for the three and nine months ended September 30, 2022 and 2021, and cash flows for the nine months ended September 30, 2022 and 2021, and should be read in conjunction with the unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q and with our Annual Report on Form 10-K for the year ended December 31, 2021. This discussion and analysis contains forward-looking statements and should also be read in conjunction with the disclosures and information contained in “Forward-Looking Statements” included elsewhere in this Quarterly Report on Form 10-Q and in “Item 1A. Risk Factors” included in the Annual Report on Form 10-K for the year ended December 31, 2021.

OVERVIEW

We provide professional business services, products and solutions that help our clients grow and succeed by better managing their finances and employees. These services are provided to businesses of various sizes, as well as individuals, governmental entities and not-for-profit enterprises throughout the United States and parts of Canada. We deliver integrated services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. Refer to Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements for a general description of services provided by each practice group.

Refer to the Annual Report on Form 10-K for the year ended December 31, 2021 for further discussion of our business and strategies, as well as the external relationships and regulatory factors that currently impact our operations.

EXECUTIVE SUMMARY

Revenue for the three months ended September 30, 2022 increased by $80.5 million, or 28.5%, to $363.3 million from $282.7 million for the same period in 2021. Same-unit revenue increased by approximately $34.8 million, or 12.3%, as compared to the same period in 2021. Revenue from newly acquired operations, net of divestitures, contributed $45.7 million, or 16.2%, of incremental revenue for the three months ended September 30, 2022 as compared to the same period in 2021.

Revenue for the nine months ended September 30, 2022 increased by $254.8 million, or 29.6%, to $1,116.9 million from $862.1 million for the same period in 2021. Same-unit revenue increased by approximately $95.3 million, or 11.1%, as compared to the same period in 2021. Revenue from newly acquired operations, net of divestitures, contributed $159.5 million, or 18.5%, of incremental revenue for the nine months ended September 30, 2022 as compared to the same period in 2021. A detailed discussion of revenue by practice group is included under "Operating Practice Groups".

Income from continuing operations was $27.5 million, or $0.53 per diluted share, in the third quarter of 2022, compared to $21.7 million, or $0.41 per diluted share, in the third quarter of 2021. For the nine months ended September 30, 2022, income from continuing operations was $116.9 million, or $2.22 per diluted share, compared to $80.5 million, or $1.50 per diluted share, for the same period in 2021. Refer to “Results of Operations – Continuing Operations” for a detailed discussion of the components of income from continuing operations.

Strategic Use of Capital

Our first priority for use of capital is to make strategic acquisitions. We also have the financing flexibility and the capacity to actively repurchase shares of our common stock. We believe that repurchasing shares of our common stock can be a prudent use of our financial resources, and that investing in our stock is an attractive use of capital and an efficient means to provide value to our stockholders. During the nine months ended September 30, 2022, we completed two acquisitions for $79.1 million in cash. We also repurchased 1.8 million shares of our common stock on open market as well as for tax withholding purposes at a total cost of approximately $75.3 million in the nine months ended September 30, 2022. Refer to Note 11, Business Combinations, to the accompanying unaudited condensed consolidated financial statements for further discussion on acquisitions.

23

During the first quarter of 2022, the CBIZ Board of Directors authorized the purchase of up to 5.0 million shares of our common stock under our Share Repurchase Program (the “Share Repurchase Program”), which may be suspended or discontinued at any time and expires on April 1, 2023. The shares may be purchased in the open market, in privately negotiated transactions, and pursuant to Rule 10b5-1 trading plans, which may include purchases from our employees, officers and directors, in accordance with the Securities and Exchange Commission (the “SEC”) rules. CBIZ management will determine the timing and amount of the transactions based on its evaluation of market conditions and other factors.

RESULTS OF OPERATIONS – CONTINUING OPERATIONS

Revenue

The following tables summarize total revenue for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended September 30,
	2022		% of Total		2021		% of Total		$ Change		% Change
	(Amounts in thousands, except percentages)
Financial Services	$	259,998	71.6	%	$	187,232	66.2	%	$	72,766	38.9	%
Benefits and Insurance Services	92,067		25.3	%	85,797		30.3	%	6,270		7.3	%
National Practices	11,197		3.1	%	9,690		3.5	%	1,507		15.6	%
Total CBIZ	$	363,262	100.0	%	$	282,719	100.0	%	$	80,543	28.5	%

	Nine Months Ended September 30,
	2022		% of Total		2021		% of Total		$ Change		% Change
	(Amounts in thousands, except percentages)
Financial Services	$	808,052	72.3	%	$	577,970	67.0	%	$	230,082	39.8	%
Benefits and Insurance Services	276,261		24.7	%	255,656		29.7	%	20,605		8.1	%
National Practices	32,623		3.0	%	28,471		3.3	%	4,152		14.6	%
Total CBIZ	$	1,116,936	100.0	%	$	862,097	100.0	%	$	254,839	29.6	%

A detailed discussion of same-unit revenue by practice group is included under “Operating Practice Groups.”

Non-qualified Deferred Compensation Plan

We sponsor a non-qualified deferred compensation plan, under which a CBIZ employee’s compensation deferral is held in a rabbi trust and invested accordingly as directed by the employee. Income and expenses related to the non-qualified deferred compensation plan, which are recorded in "Corporate and Other" for segment reporting purposes, are included in “Operating expenses”, “Gross margin” and “Corporate general and administrative expenses” and are directly offset by deferred compensation gains or losses in “Other income (expense), net” in the accompanying unaudited Condensed Consolidated Statements of Comprehensive Income. The non-qualified deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations.

Income and expenses related to the deferred compensation plan for the three and nine months end September 30, 2022 and 2021 are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
	(Amounts in thousands)
Operating (income) expenses	$	(3,995)	$	(212)	$	(23,000)	$	11,165
Corporate general and administrative (income) expenses	(697)		(86)		(3,319)		1,260
Other (expense) income, net	(4,692)		(298)		(26,319)		12,425

Excluding the impact of the above-mentioned income and expenses related to the deferred compensation plan, the operating results for the three and nine months ended September 30, 2022 and 2021 are as follows:

24

	Three Months Ended September 30,
	2022								2021
	(Amounts in thousands, except percentages)
	As Reported		Deferred Compensation Plan		Adjusted		% of Revenue		As Reported		Deferred Compensation Plan		Adjusted		% of Revenue
Gross margin	$	57,245	$	(3,995)	$	53,250	14.7	%	$	44,391	$	(212)	$	44,179	15.6	%
Operating income	41,352		(4,692)		36,660		10.1	%	31,356		(298)		31,058		11.0	%
Other (expense) income, net	(2,618)		4,692		2,074		0.6	%	(1,133)		298		(835)		(0.3)	%
Income from continuing operations before income tax expense	36,605		—		36,605		10.1	%	29,207		—		29,207		10.3	%

	Nine Months Ended September 30,
	2022								2021
	(Amounts in thousands, except percentages)
	As Reported		Deferred Compensation Plan		Adjusted		% of Revenue		As Reported		Deferred Compensation Plan		Adjusted		% of Revenue
Gross margin	$	230,884	$	(23,000)	$	207,884	18.6	%	$	162,864	$	11,165	$	174,029	20.2	%
Operating income	187,756		(26,319)		161,437		14.5	%	91,062		12,425		103,487		12.0	%
Other (expense) income, net	(24,919)		26,319		1,400		0.1	%	12,029		(12,425)		(396)		—	%
Income from continuing operations before income tax expense	157,939		—		157,939		14.1	%	106,624		—		106,624		12.4	%

Operating Expenses

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Operating expenses by segment:
Financial Services	$	220,337		$	156,178		$	64,159	41.1	%
Benefits and Insurance Services	73,321			69,039			4,282		6.2	%
National Practices	9,743			8,514			1,229		14.4	%
Corporate and Other	2,616			4,597			(1,981)		(43.1)	%
Total Operating expenses	$	306,017		$	238,328		$	67,689	28.4	%
Operating expenses % of revenue	84.2		%	84.3		%
Operating expenses excluding deferred compensation	$	310,012		$	238,540		$	71,472	30.0	%
Operating expenses excluding deferred    compensation % of revenue	85.3		%	84.4		%

25

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Operating expenses (income) by segment:
Financial Services	$	639,780		$	448,844		$	190,936	42.5	%
Benefits and Insurance Services	220,998			203,748			17,250		8.5	%
National Practices	29,218			25,542			3,676		14.4	%
Corporate and Other	(3,944)			21,099			(25,043)		N/M
Total Operating expenses	$	886,052		$	699,233		$	186,819	26.7	%
Operating expenses % of revenue	79.3		%	81.1		%
Operating expenses excluding deferred compensation	$	909,052		$	688,068		$	220,984	32.1	%
Operating expenses excluding deferred    compensation % of revenue	81.4		%	79.8		%

Three months ended September 30, 2022 compared to September 30, 2021. Total operating expenses for the three months ended September 30, 2022 increased by $67.7 million, or 28.4%, to $306.0 million as compared to $238.3 million in the same period of 2021. The non-qualified deferred compensation plan decreased operating expenses by $4.0 million for the three months ended September 30, 2022, and by $0.2 million during the same period in 2021. Excluding the non-qualified deferred compensation expenses, which was recorded in "Corporate and Other" for segment reporting purposes, operating expenses would have been $310.0 million and $238.5 million, or 85.3% and 84.4% of revenue, for the three months ended September 30, 2022 and 2021, respectively. In addition, operating expense for the three months ended September 30, 2022 included approximately $1.3 million non-recurring integration and retention costs related to the Marks Paneth acquisition.

The majority of our operating expenses relate to personnel costs, which includes (i) salaries and benefits, (ii) commissions paid to producers, (iii) incentive compensation, and (iv) stock-based compensation. Excluding the impact of deferred compensation, which was recorded in "Corporate and Other" for segment reporting purposes, operating expenses increased by approximately $71.5 million during the three months ended September 30, 2022 as compared to the same period in 2021, primarily driven by $60.9 million higher personnel costs (of which $33.7 million was the result of acquisitions), $3.0 million higher travel and entertainment costs, $2.7 million higher facility costs, $1.4 million higher technology related costs, $1.2 million higher depreciation and amortization expense, and $1.2 million higher professional services costs, as well as $1.1 million higher other discretionary spending to support business growth. Personnel costs are discussed in further detail under “Operating Practice Groups”.

Nine months ended September 30, 2022 compared to September 30, 2021. Total operating expenses for the nine months ended September 30, 2022 increased by $186.8 million, or 26.7%, to $886.1 million as compared to $699.2 million in the same period of 2021. The non-qualified deferred compensation plan decreased operating expenses by $23.0 million for the nine months ended September 30, 2022, and increased operating expenses by $11.2 million during the same period in 2021. Excluding the impact of deferred compensation, which was recorded in "Corporate and Other" for segment reporting purposes, operating expenses increased by $221.0 million during the nine months ended September 30, 2022 as compared to the same period in 2021. Operating expense for the nine months ended September 30, 2022 included approximately $8.0 million non-recurring integration and retention costs related to the Marks Paneth acquisition. The increase in operating expense was primarily driven by personnel costs increase of $179.2 million (of which $109.0 million was the result of acquisitions), $9.4 million higher travel and entertainment costs, $9.0 million higher facility costs, $6.0 million higher technology related costs, $4.7 million higher depreciation and amortization expense, and $3.7 million higher professional services costs, as well as $9.0 million higher other discretionary spending to support business growth.

26

Corporate General & Administrative (“G&A”) Expenses

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
G&A expenses	$	15,893		$	13,035		$	2,858	21.9	%
G&A expenses % of revenue	4.4		%	4.6		%
G&A expenses excluding deferred compensation	$	16,590		$	13,121		$	3,469	26.4	%
G&A expenses excluding deferred compensation % of revenue	4.6		%	4.6		%

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
G&A expenses	$	43,128		$	41,334		$	1,794	4.3	%
G&A expenses % of revenue	3.9		%	4.8		%
G&A expenses excluding deferred compensation	$	46,447		$	40,074		$	6,373	15.9	%
G&A expenses excluding deferred compensation % of revenue	4.2		%	4.6		%

Three months ended September 30, 2022 compared to September 30, 2021. The deferred compensation plan decreased G&A expenses by $0.7 million for the three months ended September 30, 2022, and decreased G&A expenses by $0.1 million during the same period in 2021. G&A expenses, excluding the impact of the deferred compensation plan, would have been $16.6 million, or 4.6% of revenue, for the three months ended September 30, 2022, compared to $13.1 million, or 4.6% of revenue, for the same period in 2021, an increase of approximately $3.5 million. The increase was primarily due to a $3.9 million increase in personnel costs as a result of adjustment to the performance-based variable compensations due to improved financial results.

Nine months ended September 30, 2022 compared to September 30, 2021. The deferred compensation plan decreased G&A expense by $3.3 million for the nine months ended September 30, 2022, but increased G&A expenses by $1.3 million during the same period in 2021. G&A expenses, excluding the impact of the deferred compensation plan, would have been $46.4 million, or 4.2% of revenue, for the nine months ended September 30, 2022, compared to $40.1 million, or 4.6% of revenue, for the same period in 2021. The increase in G&A expenses was primarily due to approximately $3.7 million higher personnel costs as a result of adjustment to the performance-based variable compensations due to improved financial results, a $1.9 million non-recurring transaction and integration costs related to the Marks Paneth acquisition, as well as $0.7 million higher other discretionary costs to support business growth.

Legal Settlement, net

Three and nine months ended September 30, 2022 compared with September 30, 2021. During the nine months ended September 30, 2021, we reached a settlement agreement with University of Pittsburgh Medical Center ("UPMC") pertaining a lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. As a result of the settlement, we recorded a settlement loss of $30.5 million for the nine months ended September 30, 2021.

27

Other (Expense) Income, Net

	Three Months Ended September 30,
	2022		2021		$ Change		% Change
	(Amounts in thousands, except percentages)
Interest expense	$	(2,305)	$	(1,016)	$	(1,289)	N/M
Gain on sale of operations, net	176		—		176		N/M
Other expense, net (1)	(2,618)		(1,133)		(1,485)		N/M
Total other (expense) income, net	$	(4,747)	$	(2,149)	$	(2,598)	N/M

	Nine Months Ended September 30,
	2022		2021		$ Change		% Change
	(Amounts in thousands, except percentages)
Interest expense	$	(5,209)	$	(2,852)	$	(2,357)	82.6	%
Gain on sale of operations, net	311		6,385		(6,074)		(95.1)	%
Other (expense) income, net (2)	(24,919)		12,029		(36,948)		N/M
Total other (expense) income, net	$	(29,817)	$	15,562	$	(45,379)	N/M

(1) Other expense, net includes a net loss of $4.7 million during the three months ended September 30, 2022, compared to a net loss of $0.3 million for the same period in 2021, associated with the value of investments held in a rabbi trust related to the deferred compensation plan, which were recorded in "Corporate and Other" for segment reporting purposes. The adjustments to the investments held in a rabbi trust related to the deferred compensation plan are offset by a corresponding increase or decrease to compensation expense, which is recorded as “Operating expenses” and “G&A expenses.” The deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations. In addition, included in Other expense, net for the three months ended September 30, 2022 and 2021, is expense of $0.4 million and $0.8 million respectively, related to net changes in the fair value of contingent consideration related to prior acquisitions.

(2) Other (expense) income, net includes a net loss of $26.3 million during the nine months ended September 30, 2022, compared to a net gain of $12.4 million for the same period in 2021, associated with the value of investments held in a rabbi trust related to the deferred compensation plan, which were recorded in "Corporate and Other" for segment reporting purposes. The adjustments to the investments held in a rabbi trust related to the deferred compensation plan are offset by a corresponding increase or decrease to compensation expense, which is recorded as “Operating expenses” and “G&A expenses.” The deferred compensation plan has no impact on “Income from continuing operations before income tax expense” or diluted earnings per share from continuing operations. In addition, included in Other (expense) income, net for the nine months ended September 30, 2022 and 2021, is expense of $1.9 million and $1.6 million, respectively, related to net changes in the fair value of contingent consideration related to prior acquisitions.

Interest Expense

Three and nine months ended September 30, 2022 compared with September 30, 2021. Our primary financing arrangement is the credit facility which was amended and restated in May, 2022. During the three months ended September 30, 2022, our average debt balance and weighted average effective interest rate was $273.2 million and 2.97%, compared to $176.5 million and 1.80% for the same period of 2021. The increase in interest expense for the three months ended September 30, 2022 as compared to the same period in 2021 was primarily driven by higher average debt balance as well as higher weighted average effective interest rate. During the nine months ended September 30, 2022, our average debt balance and interest rate was $267.2 million and 2.29% compared to $156.6 million and 1.89% for the same period of 2021. The increase in interest expense for the nine months ended September 30, 2022 as compared to the same period in 2021 was primarily driven by higher average debt balance as well as higher weighted average effective interest rate. Our indebtedness is further discussed in Note 4, Debt and Financing Arrangements, to the accompanying unaudited condensed consolidated financial statements.

Gain on Sale of Operations, Net

Three and nine months ended September 30, 2022 compared with September 30, 2021. During the nine months ended September 30, 2021, we sold a small book of business and a business unit in the Benefits and Insurance practice group. Total proceeds from the sales were $9.8 million. As a result, we recorded a net gain of $6.4 million from the sales for the nine months ended September 30, 2021.

Other (Expense) Income, Net

28

Three and nine months ended September 30, 2022 compared with September 30, 2021. For the three months ended September 30, 2022, other (expense) income, net includes a net loss of $4.7 million associated with the non-qualified deferred compensation plan. For the same period in 2021, other (expense) income, net includes a net loss of $0.3 million associated with the non-qualified deferred compensation plan. Excluding the impact of the deferred compensation plan, other (expense) income, net decreased by $2.9 million in 2022 as compared to 2021 primarily due to a $2.4 million gain related to the sale of a book of business as well as $0.4 million lower adjustment to the fair value of the contingent purchase price liability.

For the nine months ended September 30, 2022, other (expense) income, net includes a net loss of $26.3 million associated with the non-qualified deferred compensation plan. For the same period in 2021, other (expense) income, net includes a net gain of $12.4 million associated with the non-qualified deferred compensation plan. Excluding the impact of the deferred compensation plan, other (expense) income, net decreased by $1.8 million in 2022 as compared to 2021 due to a $2.4 million gain related to the sale of a book of business in 2022 as compared to an immaterial gain from the sale of certain assets in 2021.

Income Tax Expense

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Income tax expense	$	9,131		$	7,512		$	1,619	21.6	%
Effective tax rate	24.9		%	25.7		%

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Income tax expense	$	41,074		$	26,100		$	14,974	57.4	%
Effective tax rate	26.0		%	24.5		%

Three and nine months ended September 30, 2022 compared with September 30, 2021. The effective tax rate for the three months ended September 30, 2022 was 24.9%, compared to an effective tax rate of 25.7% for the comparable period in 2021. The decrease in the effective tax rate year over year was primarily due to a larger tax benefit recognized related to stock-based compensation expense. This tax benefit was partially offset by the tax effect of higher non-deductible expenses during the third quarter of 2022 as compared to the same period in 2021.

The effective tax rate for the nine months ended September 30, 2022 was 26.0%, compared to an effective tax rate of 24.5% for the same period in 2021. The increase in the effective tax rate year over year was primarily due to the effect of higher pre-tax income on our tax benefit related to stock-based compensation. In addition, we incurred higher non-deductible expenses during the nine months ended September 30, 2022 as compared to the same period in 2021 which also contributed to the increase in the effective tax rate.

Operating Practice Groups

We deliver our integrated services through three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. A description of these groups' operating results and factors affecting their businesses is provided below.

Same-unit revenue represents total revenue adjusted to reflect comparable periods of activity for acquisitions and divestitures. Divested operations represent operations that did not meet the criteria for treatment as discontinued operations.

29

Financial Services

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Revenue
Same-unit	$	214,265		$	187,232		$	27,033	14.4	%
Acquired businesses	45,733			—			45,733
Total revenue	$	259,998		$	187,232		$	72,766	38.9	%
Operating expenses	220,337			156,178			64,159		41.1	%
Gross margin / Operating income	$	39,661		$	31,054		$	8,607	27.7	%
Total other income, net	279			18			261		N/M
Income from continuing operations before income tax expense	39,940			31,072			8,868		28.5	%
Gross margin percent	15.3		%	16.6		%

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Revenue
Same-unit	$	647,343		$	577,970		$	69,373	12.0	%
Acquired businesses	160,709			—			160,709
Total revenue	$	808,052		$	577,970		$	230,082	39.8	%
Operating expenses	639,780			448,844			190,936		42.5	%
Gross margin / Operating income	$	168,272		$	129,126		$	39,146	30.3	%
Total other income, net	585			310			275		88.7	%
Income from continuing operations before income tax expenses	168,857			129,436			39,421		30.5	%
Gross margin percent	20.8		%	22.3		%

Three months ended September 30, 2022 compared to September 30, 2021

Revenue

The Financial Services practice group revenue for the three months ended September 30, 2022 grew by 38.9% to $260.0 million from $187.2 million during the same period in 2021. Same-unit revenue grew by $27.0 million, or 14.4%, across all service lines, primarily driven by those units that provide traditional accounting and tax-related services, which increased $19.4 million, and an increase of $7.1 million in government healthcare compliance business, as well as an increase of approximately $0.5 million in those units that provide project-oriented advisory services. The impact of acquired businesses contributed $45.7 million, or 17.6% of 2022 revenue, of which Marks Paneth and Stinnett contributed a total of $40.7 million, or 15.7% of 2022 revenue.

We provide a range of services to affiliated CPA firms under joint referral and administrative service agreements (“ASAs”). Fees earned under the ASAs are recorded as revenue in the accompanying Condensed Consolidated Statements of Comprehensive Income and were approximately $54.1 million and $39.7 million for the three months ended September 30, 2022 and 2021, respectively.

Operating Expenses

Operating expenses increased by $64.2 million, or 41.1%, as compared to the same period last year. Personnel costs increased by $51.1 million, or 32.7%, with acquisitions contributing approximately $33.7 million to the increase. Compared to the same period in 2021, facility costs, depreciation and amortization costs, professional and consulting services, technology costs, as well as marketing and recruiting costs increased by approximately $2.9 million, $1.4 million, $1.4 million, $0.9 million, and $0.8 million respectively. In addition, travel and entertainment costs increase by approximately $2.0 million and other discretionary costs increased by approximately $3.7 million

30

to support the business growth. Operating expense as a percentage of revenue decreased to 84.7% for the three months ended September 30, 2022 from 83.4% of revenue for the prior year quarter.

Nine months ended September 30, 2022 compared to September 30, 2021

Revenue

Revenue for the nine months ended September 30, 2022 grew by 39.8% to $808.1 million from $578.0 million during the same period in 2021. Same-unit revenue grew by $69.4 million, or 12.0%, across all service lines, primarily driven by those units that provide traditional accounting and tax-related services, which increased $42.8 million, an increase of $15.3 million in government healthcare compliance business, and an increase of approximately $11.0 million in those units that provide project-oriented advisory services. The impact of acquired businesses contributed $160.7 million, or 19.9% of 2022 revenue, of which Marks Paneth and Stinnett contributed a total of $119.9 million, or 14.8% of 2022 revenue.

Fees earned under the ASAs, as described above, were approximately $191.1 million and $139.7 million for the nine months ended September 30, 2022 and 2021, respectively.

Operating Expenses

Operating expenses increased by $190.9 million, or 42.5%, as compared to the same period last year. Personnel costs increased by $146.6 million, or 32.7%, with acquisitions contributing approximately $110.0 million to the increase. Compared to the same period in 2021, facility costs, depreciation and amortization costs, technology costs, professional and consulting services, as well as marketing and recruiting costs increased by approximately $9.5 million, $5.5 million, $4.4 million, $3.6 million, and $2.9 million, respectively, primarily due to the Marks Paneth acquisition. In addition, travel and entertainment costs increased by approximately $6.0 million and other discretionary costs increased by approximately $12.4 million to support the business growth. Operating expense as a percentage of revenue increased to 79.2% during the nine months ended September 30, 2022 from 77.7% of revenue during the same period in 2021.

Benefits and Insurance Services

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Revenue
Same-unit	$	92,067		$	85,797		$	6,270	7.3	%
Total revenue	$	92,067		$	85,797		$	6,270	7.3	%
Operating expenses	73,321			69,039			4,282		6.2	%
Gross margin / Operating income	$	18,746		$	16,758		$	1,988	11.9	%
Total other (expense) income, net	2,398			(9)			2,407		N/M
Income from continuing operations before income tax expense	21,144			16,749			4,395		26.2	%
Gross margin percent	20.4		%	19.5		%

31

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Revenue
Same-unit	$	276,261		$	254,460		$	21,801	8.6	%
Divested operations	—			1,196			(1,196)
Total revenue	$	276,261		$	255,656		$	20,605	8.1	%
Operating expenses	220,998			203,748			17,250		8.5	%
Gross margin/ Operating income	$	55,263		$	51,908		$	3,355	6.5	%
Total other income, net	2,361			7,248			(4,887)		(67.4)	%
Income from continuing operations before income tax expenses	57,624			59,156			(1,532)		(2.6)	%
Gross margin percent	20.0		%	20.3		%

Three months ended September 30, 2022 compared to September 30, 2021

Revenue

The Benefits and Insurance Services practice group revenue increased by $6.3 million, or 7.3%, to $92.1 million during the three months ended September 30, 2022 compared to $85.8 million for the same period in 2021. The increase was across all service lines, primarily driven by $3.5 million increase in employee benefit and retirement benefit services lines, $1.3 million increase in the property and casualty services, and $0.8 million in payroll related services, as well as growth in our other project based services.

Operating Expenses

Operating expenses increased by $4.3 million, or 6.2%, when compared to the same period last year. Personnel costs increased by $3.5 million, or 5.1%, primarily due to timing of annual merit increases as well as investment in producers. Compared to the same period in 2021, travel and entertainment cost, technology costs, as well as marketing and recruiting costs increased by approximately $0.3 million, $0.2 million, and $0.2 million, respectively. In addition, other operating expenses and other direct costs increased by approximately $0.3 million to support increased business activities, offset by $0.2 million lower bad debt expense as compared to the same period in 2021. Operating expense as a percentage of revenue slightly improved to 79.6% for the quarter ended September 30, 2022 from 80.5% of revenue for the same period in 2021.

Total Other (Expense) Income, Net

We sold a small book of business in our property and casualty service line during the three months ended September 30, 2022 for total proceeds of $2.5 million. Net gain from the sale was approximately $2.4 million.

Nine months ended September 30, 2022 compared to September 30, 2021

Revenue

The Benefits and Insurance Services practice group revenue increased by $20.6 million, or 8.1%, to $276.3 million during the nine months ended September 30, 2022 compared to $255.7 million for the same period in 2021. Same-unit revenue increased by $21.8 million, or 8.6% when compared to the same period in 2021. The increase was across all service lines, primarily driven by $8.7 million increase in the property and casualty services, $8.4 million increase in employee benefit and retirement benefit services lines, and $1.6 million in payroll related services as well as growth in our other project based services.

Operating Expenses

Operating expenses increased by $17.3 million, or 8.5%, when compared to the same period last year. Personnel cost increased by $12.4 million, or 6.1%, primarily due to timing of annual merit increases, bonus accrual, as well as investment in producers. Compared to the same period in 2021, travel and entertainment cost, technology costs, marketing and recruiting costs, as well as bad debt expense increased by approximately $1.4 million, $0.6 million, $0.5 million and $0.5 million, respectively. In addition, other operating expenses and other direct costs increased by approximately $2.0 million to support increased business activities. Operating expense as a percentage of revenue

32

remained relatively unchanged at 80.0% during the nine months ended September 30, 2022 as compared to 79.7% of revenue for the same period in 2021.

Total Other Income, Net

We sold a business unit during the nine months ended September 30, 2021 for total proceeds of $9.8 million. Net gain from the sale was approximately $6.4 million. We also sold a small book of business in our property and casualty service line during the nine months ended September 30, 2022 for total proceeds of $2.5 million and recorded a net gain of approximately $2.4 million from the sale.

National Practices

	Three Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Same-unit revenue	$	11,197		$	9,690		$	1,507	15.6	%
Operating expenses	9,743			8,514			1,229		14.4	%
Gross margin / Operating income	$	1,454		$	1,176		$	278	23.6	%
Total other income, net	8			1			7		N/M
Income from continuing operations before income tax expense	1,462			1,177			285		24.2	%
Gross margin percent	13.0		%	12.1		%

	Nine Months Ended September 30,
	2022			2021			$ Change		% Change
	(Amounts in thousands, except percentages)
Same-unit revenue	$	32,623		$	28,471		$	4,152	14.6	%
Operating expenses	29,218			25,542			3,676		14.4	%
Gross margin / Operating income	$	3,405		$	2,929		$	476	16.3	%
Total other income, net	9			1			8		N/M
Income from continuing operations before income tax expenses	3,414			2,930			484		16.5	%
Gross margin percent	10.4		%	10.3		%

Three and nine months ended September 30, 2022 compared with September 30, 2021

Revenue and Operating Expenses

The National Practices group is primarily driven by a cost-plus contract with a single client, which has existed since 1999. The cost-plus contract is a five-year contract with the most recent renewal through December 31, 2023. Revenues from this single client accounted for approximately 75% of the National Practice group’s revenue. During the three and nine months ended September 30, 2022, revenue increased by $1.5 million, or 15.6%, and $4.2 million, or 14.6%, respectively, while operating expenses increased by $1.2 million, or 14.4%, and $3.7 million, or 14.4%, respectively.

33

Corporate and Other

Corporate and Other are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

	Three Months Ended September 30,
	2022		2021		$ Change	% Change
	(Amounts in thousands, except percentages)
Operating expenses	$	2,616	$	4,597	(1,981)	(43.1)	%
Corporate general and administrative expenses	15,893		13,035		2,858	21.9	%
Operating loss	(18,509)		(17,632)		(877)	5.0	%
Total other expense, net	(7,432)		(2,159)		(5,273)	N/M
Loss from continuing operations before income tax expense	(25,941)		(19,791)		(6,150)	31.1	%

	Nine Months Ended September 30,
	2022		2021		$ Change	% Change
	(Amounts in thousands, except percentages)
Operating (income) expenses	$	(3,944)	$	21,099	(25,043)	N/M
Corporate general and administrative expenses	43,128		41,334		1,794	4.3	%
Legal settlement, net	—		30,468		(30,468)	(100.0)	%
Operating loss	(39,184)		(92,901)		53,717	(57.8)	%
Total other (expense) income, net	(32,772)		8,003		(40,775)	N/M
Loss from continuing operations before income tax expenses	(71,956)		(84,898)		12,942	(15.2)	%

Three months ended September 30, 2022 compared to September 30, 2021

Total operating expenses decreased by $2.0 million, or 43.1%, during the three months ended September 30, 2022, as compared to the same period in 2021. The non-qualified deferred compensation plan decreased operating expenses by $4.0 million for the three months ended September 30, 2022 and decreased operating expenses by $0.2 million during the same period in 2021. Excluding the non-qualified deferred compensation expenses, operating expense increased by approximately $1.8 million, primarily driven by higher personnel and facility costs to support business growth.

Total corporate general and administrative expenses increased by $2.9 million, or 21.9%, during the three months ended September 30, 2022, as compared to the same period in 2021. The non-qualified deferred compensation plan decreased corporate general and administrative expenses by $0.7 million for the three months ended September 30, 2022, and by $0.1 million during the same period in 2021. Excluding the non-qualified deferred compensation expenses, corporate general and administrative expense increased by approximately $3.5 million, primarily driven by $3.9 million higher personnel costs, offset by $0.4 million lower costs primarily lower professional services costs as compared to the same period in 2021.

Total other (expense) income, net increased by $5.3 million during the three months ended September 30, 2022, as compared to the same period in 2021. For the three months ended September 30, 2022, total other expense, net includes a net loss of $4.7 million associated with the non-qualified deferred compensation plan. For the same period in 2021, other income, net includes a net loss of $0.3 million associated with the non-qualified deferred compensation plan. Excluding the impact of the non-qualified deferred compensation plan, total other expense, net would have been $2.7 million in 2022 and $1.9 million in 2021, a change of $0.8 million primarily attributed to $1.3 million higher interest expense, offset by $0.4 million lower fair value adjustments to the contingent purchase price.

Nine months ended September 30, 2022 compared to September 30, 2021

34

Total operating expenses decreased by $25.0 million, or 118.7%, during the nine months ended September 30, 2022, as compared to the same period in 2021. The non-qualified deferred compensation plan decreased operating expenses by $23.0 million for the nine months ended September 30, 2022, and increased operating expense by $11.2 million during the same period in 2021. Excluding the non-qualified deferred compensation expenses, operating expense increased by approximately $9.1 million, primarily driven by higher personnel costs and facility costs to support business growth.

Total G&A expenses increased by $1.8 million, or 4.3%, during the nine months ended September 30, 2022, as compared to the same period in 2021. The non-qualified deferred compensation plan decreased G&A expenses by $3.3 million for the nine months ended September 30, 2022, and increased G&A expense by $1.3 million during the same period in 2021. Excluding the non-qualified deferred compensation expenses, G&A expense increased by approximately $6.4 million, primarily driven by $3.7 million higher personnel costs, $1.9 million higher transaction and integration related professional services costs associated with the Marks Paneth acquisition, $0.5 million higher travel and entertainment costs, and $0.3 million higher other discretionary costs to support the business growth.

During the nine months ended September 30, 2021, we reached a settlement agreement with UPMC pertaining a lawsuit filed in the U.S. District Court for the Western District of Pennsylvania. As a result of the settlement, we recorded a settlement loss of $30.5 million for the nine months ended September 30, 2021.

Total other (expense) income, net increased by $40.8 million, or 509.5%, during the nine months ended September 30, 2022, as compared to the same period in 2021. Total other (expense) income, net for the nine months ended September 30, 2022 includes a net loss of $26.3 million associated with the non-qualified deferred compensation plan. For the same period in 2021, total other income, net includes a net gain of $12.4 million associated with the non-qualified deferred compensation plan. Excluding the impact of the non-qualified deferred compensation plan, total other (expense) income, net increased by $2.0 million, primarily due to $2.4 million higher interest expense due to higher average outstanding balance and interest rates during 2022 as compared to 2021, offset by $0.4 million decrease in miscellaneous expenses.

LIQUIDITY

Our principal sources of liquidity are cash generated from operating activities and financing activities. Our cash flows from operating activities are driven primarily by our operating results and changes in our working capital requirements while our cash flows from financing activities are dependent upon our ability to access credit or other capital. We historically maintain low cash levels and apply any available cash to pay down the outstanding debt balance.

We historically experience a use of cash to fund working capital requirements during the first quarter of each fiscal year. This is primarily due to the seasonal accounting and tax services period under the Financial Services practice group, as well as payment of accrued employees' incentives programs. Upon completion of the seasonal accounting and tax services period, cash provided by operations during the remaining three quarters of the fiscal year substantially exceeds the use of cash in the first quarter of the fiscal year.

Accounts receivable balances increase in response to the first nine months revenue generated by the Financial Services practice group. A significant amount of this revenue is billed and collected in subsequent quarters. Days sales outstanding (“DSO”) from continuing operations represent accounts receivable and unbilled revenue (net of realization adjustments) at the end of the period, divided by trailing twelve months daily revenue. We provide DSO data because such data is commonly used as a performance measure by analysts and investors and as a measure of our ability to collect on receivables in a timely manner. DSO was 93 days and 88 days at September 30, 2022 and 2021, respectively. DSO at December 31, 2021 was 71 days.

The following table presents selected cash flow information. For additional details, refer to the accompanying Condensed Consolidated Statements of Cash Flows.

	Nine Months Ended September 30,
	2022		2021
	(Amounts in thousands)
Net cash provided by operating activities	$	60,059	$	80,946
Net cash used in investing activities	(95,550)		(70,728)
Net cash provided by financing activities	6,025		1,678
Net (decrease) increase in cash, cash equivalents and restricted cash	$	(29,466)	$	11,896

35

Operating Activities - Cash provided by operating activities was $60.1 million during the nine months ended September 30, 2022 and primarily due to net income of $116.9 million and certain non-cash items, such as depreciation and amortization expense of $24.7 million, deferred income tax of $5.7 million, and stock-based compensation expense of $12.0 million. The cash inflow was offset by working capital use of $100.0 million. Cash provided by operating activities was $80.9 million during the nine months ended September 30, 2021 and primarily due to net income of $80.5 million and certain non-cash items, such as depreciation and amortization expense of $19.9 million, deferred income tax of $7.1 million, and stock-based compensation expense of $8.4 million. The cash inflow was offset by working capital use of $30.4 million

Investing Activities - Cash used in investing activities during the nine months ended September 30, 2022 was $95.6 million and consisted primarily of $79.3 million used for business acquisition, $6.0 million in capital expenditures, $8.4 million net activity related to funds held for clients, and $4.7 million in other activities related to working capital payments and notes receivable. The use of cash was offset by $2.9 million cash inflow primarily related to $2.5 million proceeds from the sale of a small book of business as well as receipts of cash payments related to certain prior divestitures. Cash used in investing activities during the nine months ended September 30, 2021 was $70.7 million and consisted primarily of $66.2 million used for business acquisitions, $6.5 million in capital expenditures, and $8.0 million net activity related to funds held for clients. The use of cash was offset by other investing activities, such as proceeds from sales of divested operations of $9.8 million.

The balances in funds held for clients and client fund obligations can fluctuate with the timing of cash receipts and the related cash payments. The nature of these accounts is further described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021.

Financing Activities - Cash provided by financing activities during the nine months ended September 30, 2022 was $6.0 million and primarily consisted of $115.8 million in net proceeds from the credit facility and $8.0 million proceeds from exercise of stock options, partially offset by $73.3 million in share repurchases, $30.0 million net decrease in client fund obligations, $12.4 million in contingent consideration payments related to prior acquisitions and $2.1 million paid as deferred financing costs related to the 2022 credit facility. Cash used in financing activities during the nine months ended September 30, 2021 was $1.7 million and primarily consisted of $82.2 million in net proceeds from the credit facility, $8.4 million net increase in client fund obligations and $7.1 million proceeds from exercise of stock options, partially offset by $88.0 million in share repurchases and $7.9 million in contingent consideration payments related to prior acquisitions.

CAPITAL RESOURCES

Credit Facility - At September 30, 2022, we had $271.1 million outstanding under the 2022 credit facility as well as $5.7 million outstanding letters of credit. Available funds under the 2022 credit facility, based on the terms of the commitment, were approximately $310.9 million at September 30, 2022. The weighted average interest rate under the credit facility was 2.29% during the nine months ended September 30, 2022, compared to 1.89% for the same period in 2021. The credit facility allows for the allocation of funds for future strategic initiatives, including acquisitions and the repurchase of our common stock, subject to the terms and conditions of the 2022 credit facility.

Debt Covenant Compliance - Under the 2022 credit facility, we are required to meet certain financial covenants with respect to (i) total leverage ratio and (ii) interest charge coverage ratio. We are in compliance with our financial covenants as of September 30, 2022. Our ability to service our debt and to fund future strategic initiatives will depend upon our ability to generate cash in the future. For further discussion regarding our 2022 credit facility and debt, refer to Note 4, Debt and Financing Arrangements, to the accompanying unaudited condensed consolidated financial statements.

Use of Capital - Our first priority for use of capital is to make strategic acquisitions. We also have the financing flexibility and the capacity to actively repurchase shares of our common stock. We believe that repurchasing shares of our common stock can be a prudent use of our financial resources, and that investing in our stock is an attractive use of capital and an efficient means to provide value to our stockholders. During the nine months ended September 30, 2022, we completed two acquisitions for $79.1 million in cash. We also repurchased 1.8 million shares of our common stock at a total cost of approximately $75.3 million during the nine months ended September 30, 2022. Refer to Note 11, Business Combinations, to the accompanying unaudited condensed consolidated financial statements for further discussion on acquisitions.

36

Cash Requirements for 2022 - Cash requirements for the remainder of 2022 will include acquisitions, interest payments on debt, seasonal working capital requirements, contingent purchase price payments for previous acquisitions, share repurchases and capital expenditures. We believe that cash provided by operations, as well as available funds under our credit facility will be sufficient to meet cash requirements.

OFF-BALANCE SHEET ARRANGEMENTS

We maintain administrative service agreements with independent CPA firms (as described more fully under “Business – Financial Services” and in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021), which qualify as variable interest entities. The accompanying unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations, or cash flows of CBIZ.

We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $5.7 million and $3.4 million at September 30, 2022 and December 31, 2021, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.3 million at September 30, 2022 and December 31, 2021, respectively.

We have various agreements under which we may be obligated to indemnify the other party with respect to certain matters. Generally, these indemnification clauses are included in contracts arising in the normal course of business under which we customarily agree to hold the other party harmless against losses arising from a breach of representations, warranties, covenants or agreements, related to matters such as title to assets sold and certain tax matters. Payment by us under such indemnification clauses is generally conditioned upon the other party making a claim. Such claims are typically subject to challenge by us and to dispute resolution procedures specified in the particular contract. Further, our obligations under these agreements may be limited in terms of time and/or amount and, in some instances, we may have recourse against third parties for certain payments made by us. It is not possible to predict the maximum potential amount of future payments under these indemnification agreements due to the conditional nature of our obligations and the unique facts of each particular agreement. Historically, we have not made any payments under these agreements that have been material individually or in the aggregate. As of September 30, 2022, we are not aware of any material obligations arising under indemnification agreements that would require payment.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

The SEC defines critical accounting policies as those that are most important to the portrayal of a company’s financial condition and results and that require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain.

Our discussion and analysis of our results of operations, financial condition and liquidity are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements. As more information becomes known, these estimates and assumptions could change, which would have an impact on actual results that may differ materially from these estimates and judgments under different assumptions. We have not made any changes to our critical accounting policies and estimates as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

NEW ACCOUNTING PRONOUNCEMENTS

Refer to Note 2, New Accounting Pronouncements, to the accompanying unaudited condensed consolidated financial statements for a discussion of recently issued accounting pronouncements.

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical fact included in this Quarterly

37

Report, including without limitation, "Management's Discussion and Analysis of Financial Condition and Results of Operations" regarding our financial position, business strategy and plans and objectives for future performance are forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Forward-looking statements are commonly identified by the use of such terms and phrases as "intends", "believes", "estimates", "expects", "projects", "anticipates", "foreseeable future", "seeks", and words or phrases of similar import in connection with any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance or results of current and anticipated services, sales efforts, expenses, and financial results. From time to time, we also may provide oral or written forward-looking statements in other materials we release to the public. Any or all of our forward-looking statements in this Quarterly Report on Form 10-Q and in any other public statements that we make, are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include, but are not limited to, the impact of COVID-19 on the Company’s business and operations and those of our clients; the Company’s ability to adequately manage and sustain its growth; the Company’s dependence on the current trend of outsourcing business services; the Company’s dependence on the services of its CEO and other key employees; competitive pricing pressures; general business and economic conditions; and changes in governmental regulation and tax laws affecting the Company’s insurance business or its business service operations. Such forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Should one or more of these risks materialize, or should the underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected.

Consequently, no forward-looking statement can be guaranteed. A more detailed description of risk factors may be found in “Item 1A, Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2021. Except as required by the federal securities laws, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our filings with the SEC, such as quarterly, periodic and annual reports.

38

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our floating rate debt under the 2022 credit facility exposes us to interest rate risk. Interest rate risk results when the maturity or repricing intervals of interest-earning assets and interest-bearing liabilities are different. A change in the Federal Funds Rate, or the reference rate set by Bank of America, N.A., would affect the rate at which we could borrow funds under the credit facility. The balance outstanding under our credit facility at September 30, 2022 was $271.1 million, of which $156.1 million is subject to rate risk. If market rates were to increase or decrease 100 basis points from the levels at September 30, 2022, interest expense would increase or decrease approximately $1.6 million annually.

We do not engage in trading market risk sensitive instruments. We periodically use interest rate swaps to manage interest rate risk exposure. The interest rate swaps effectively modify our exposure to interest rate risk, primarily through converting portions of our floating rate debt under the credit facility to a fixed rate basis. These agreements involve the receipt or payment of floating rate amounts in exchange for fixed rate interest payments over the life of the agreements without an exchange of the underlying principal amounts.

At September 30, 2022, we had four interest rate swaps with notional values, fixed rates of interest and expiration dates of (i) $15.0 million – 2.571% - June, 2023, (ii) $50.0 million – 0.834% - April, 2025, (iii) $30.0 million – 1.186% - December, 2026, and (iv) $20.0 million - 2.45% - August, 2027, respectively. Management will continue to evaluate the potential use of interest rate swaps as we deem appropriate under certain operating and market conditions. We do not enter into derivative instruments for trading or speculative purposes.

In connection with the services provided by our payroll operations, funds collected from our clients’ accounts in advance are segregated and may be invested in short-term investments, such as corporate and municipal bonds. In accordance with our investment policy, all investments carry an investment grade rating at the time of the initial acquisition, and are classified as available-for-sale securities. At each respective balance sheet date, these investments are adjusted to fair value with fair value adjustments being recorded to other comprehensive income or loss and reflected in the accompanying Condensed Consolidated Statements of Comprehensive Income for the respective period. If an investment is deemed to be other-than-temporarily impaired due to credit loss, then the adjustment is recorded to "Other (expense) income, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income. Refer to Note 6, Financial Instruments, and Note 7, Fair Value Measurements, to the accompanying unaudited condensed consolidated financial statements for further discussion regarding these investments and the related fair value assessments.

ITEM 4. CONTROLS AND PROCEDURES

(a) Disclosure Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Management has evaluated the effectiveness of our disclosure controls and procedures (“Disclosure Controls”) as of the end of the period covered by this report. This evaluation (“Controls Evaluation”) was done with the participation of the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”). Disclosure Controls are controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure Controls include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file under the Exchange Act is accumulated and communicated to management, including the CEO and CFO as appropriate, to allow timely decisions regarding required disclosure.

Limitations on the Effectiveness of Controls

Management, including our CEO and CFO, does not expect that our Disclosure Controls or our internal control over financial reporting will prevent all errors and all fraud. Although our Disclosure Controls are designed to provide reasonable assurance of achieving their objective, a control system, no matter how well conceived and operated, can provide only reasonable, but not absolute, assurance that the objectives of a control system are met. Further, any control system reflects limitations on resources, and the benefits of a control system must be considered relative to its costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within CBIZ have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can

39

occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of a control. A design of a control system is also based upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

Conclusions

Our Disclosure Controls are designed to provide reasonable assurance of achieving their objectives and, based upon the Controls Evaluation, our CEO and CFO have concluded that as of the end of the period covered by this report, CBIZ’s Disclosure Controls were effective at that reasonable assurance level.

(b) Internal Control over Financial Reporting

On January 1, 2022, we completed the Marks Paneth acquisition. We are in the process of integrating Marks Paneth into our system of internal control over financial reporting. Except for the Marks Paneth acquisition, there have been no changes to our internal control over financial reporting during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

40

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Information regarding certain legal proceedings in which we are involved is incorporated by reference from Note 5, Commitments and Contingencies, to the accompanying condensed consolidated financial statements.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 as filed with the SEC. These risks could materially and adversely affect the business, financial condition and results of operations of CBIZ.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

(a) Recent sales of unregistered securities

During the nine months ended September 30, 2022, approximately 45 thousand shares of our common stock were issued as payment for contingent consideration for previous acquisitions. The foregoing shares were issued in transactions not involving a public offering in reliance on the exemption from registration afforded by Section 4(a)(2) of the Securities Act. The persons to whom the shares were issued had access to full information about the Company and represented that they acquired the shares for their own account and not for the purpose of distribution. The certificates for the shares contain a restrictive legend advising that the shares may not be offered for sale, sold, or otherwise transferred without having first been registered under the Securities Act or pursuant to an exemption from the Securities Act.

(b) Issuer purchases of equity securities

On February 10, 2022, our Board of Directors authorized the continuation of the Share Repurchase Program, which has been renewed annually for the past eighteen years. It was effective beginning April 1, 2022, and the amount of shares to be purchased was reset to five million, and expires one year from the effective date. The Share Repurchase Program allows us to purchase shares of our common stock (i) in the open market, (ii) in privately negotiated transactions, and (iii) under Rule 10b5-1 trading plans. Privately negotiated transactions may include purchases from our employees, Officers and Directors, in accordance with SEC rules. Rule 10b5-1 trading plans allow for repurchases during periods when we would not normally be active in the trading market due to regulatory restrictions. The Share Repurchase Program does not obligate us to acquire any specific number of shares and may be suspended at any time.

Shares repurchased under the Share Repurchase Program during the three months ended September 30, 2022 (reported on a trade-date basis) are summarized in the table below (amounts in thousands, except per share data). Average price paid per share includes fees and commissions.

	Issuer Purchases of Equity Securities
Third Quarter Purchases	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plan	Maximum Number of Shares That May Yet Be Purchased Under the Plan
July 1 – July 31, 2022	201	$	40.93	201	4,040
August 1 – August 31, 2022	202	$	45.57	202	3,838
September 1 – September 30, 2022	341	$	43.96	341	3,497
Third quarter purchases	744	$	43.58	744

According to the terms of our 2022 credit facility, our ability to declare or make any dividend payments is limited. Refer to Note 4, Debt and Financing Arrangements, to the condensed consolidated financial statements for a description of working capital restrictions and limitations on the payment of dividends.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

41

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

42

Item 6. Exhibits

10.1	Amendment to Loan Agreement by and among CBIZ Benefit and Insurance, Inc. and The Huntington National Bank.
31.1 *	Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes Oxley Act of 2002.
31.2 *	Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 **	Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 **	Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document*
101.SCH	Inline XBRL Taxonomy Extension Schema Document*
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in the Exhibit 101 attachments)

*    Indicates documents filed herewith.

**    Indicates document furnished herewith.

43

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			CBIZ, Inc.
			(Registrant)
Date:	October 28, 2022	By:	/s/ Ware H. Grove
			Ware H. Grove
			Chief Financial Officer
			Duly Authorized Officer and Principal Financial Officer

EX-10.1

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF CBIZ, INC.

I, Jerome P. Grisko, Jr., President and Chief Executive Officer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CBIZ, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 28, 2022	/s/ JEROME P. GRISKO, JR.
	Jerome P. Grisko, Jr.
	President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF CBIZ, INC.

I, Ware H. Grove, Chief Financial Officer, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of CBIZ, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s first fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: October 28, 2022	/s/ WARE H. GROVE
	Ware H. Grove
	Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF CBIZ, INC.

This certification is provided pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, and accompanies the Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Form 10-Q”) of CBIZ, Inc. (the “Issuer”) filed with the Securities and Exchange Commission on the date hereof.

I, Jerome P. Grisko, Jr., the President and Chief Executive Officer of the Issuer, certify that to the best of my knowledge:

(i)the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii)the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Date: October 28, 2022	/s/ JEROME P. GRISKO, JR.
	Jerome P. Grisko, Jr.
	President and Chief Executive Officer

Subscribed and sworn to before me on this 28th day of October, 2022.

/s/ MICHAEL W. GLEESPEN
Name:	Michael W. Gleespen
Title:	Notary Public & Attorney-At-Law

Registered in Franklin County, Ohio

No Expiration Date

EX-32.2

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER OF CBIZ, INC.

This certification is provided pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, and accompanies the Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Form 10-Q”) of CBIZ, Inc. (the “Issuer”) filed with the Securities and Exchange Commission on the date hereof.

I, Ware H. Grove, the Chief Financial Officer of the Issuer, certify that to the best of my knowledge:

(i)the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

(ii)the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.

Date: October 28, 2022	/s/ WARE H. GROVE
	Ware H. Grove
	Chief Financial Officer

Subscribed and sworn to before me on this 28th day of October, 2022.

/s/ MICHAEL W. GLEESPEN
Name:	Michael W. Gleespen
Title:	Notary Public & Attorney-At-Law

Registered in Franklin County, Ohio

No Expiration Date

XML

Cover - shares	9 Months Ended
	Sep. 30, 2022	Oct. 24, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	1-32961
Entity Registrant Name	CBIZ, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	22-2769024
Entity Address, Address Line One	6801 Brecksville Rd
Entity Address, Address Line Two	Door N
Entity Address, City or Town	Independence
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	44131
City Area Code	216
Local Phone Number	447-9000
Title of 12(b) Security	Common Stock, $0.01 Par Value
Trading Symbol	CBZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		50,832,709
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000944148
Current Fiscal Year End Date	--12-31

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 2,040	$ 1,997
Restricted cash	39,555	30,383
Accounts receivable, net	398,970	242,168
Other current assets	17,065	19,217
Current assets before funds held for clients	457,630	293,765
Funds held for clients	125,451	157,909
Total current assets	583,081	451,674
Non-current assets:
Property and equipment, net	45,469	43,423
Goodwill and other intangible assets, net	957,186	840,783
Assets of deferred compensation plan	111,060	136,321
Operating lease right-of-use assets, net	191,699	151,145
Other non-current assets	11,123	4,588
Total non-current assets	1,316,537	1,176,260
Total assets	1,899,618	1,627,934
Current liabilities:
Accounts payable	74,247	65,757
Income taxes payable	14,037	1,671
Accrued personnel costs	125,310	114,032
Contingent purchase price liabilities	61,355	34,373
Operating lease liabilities	36,519	30,586
Other current liabilities	19,045	18,755
Current liabilities before client fund obligations	330,513	265,174
Client fund obligations	128,091	158,115
Total current liabilities	458,604	423,289
Non-current liabilities:
Bank debt	271,100	155,300
Debt issuance costs	(2,164)	(449)
Total long-term debt, net	268,936	154,851
Income taxes payable	2,069	1,727
Deferred income taxes, net	22,566	15,440
Deferred compensation plan obligations	111,060	136,321
Contingent purchase price liabilities	79,853	44,766
Operating lease liabilities	181,841	145,808
Other non-current liabilities	564	1,184
Total non-current liabilities	666,889	500,097
Total liabilities	1,125,493	923,386
STOCKHOLDERS' EQUITY
Common stock	1,361	1,352
Additional paid in capital	793,514	770,117
Retained earnings	745,614	628,762
Treasury stock	(769,981)	(694,716)
Accumulated other comprehensive income (loss)	3,617	(967)
Total stockholders’ equity	774,125	704,548
Total liabilities and stockholders’ equity	$ 1,899,618	$ 1,627,934

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Revenue	$ 363,262	$ 282,719	$ 1,116,936	$ 862,097
Operating expenses	306,017	238,328	886,052	699,233
Gross margin	57,245	44,391	230,884	162,864
Corporate general and administrative expenses	15,893	13,035	43,128	41,334
Legal settlement, net	0	0	0	30,468
Operating income	41,352	31,356	187,756	91,062
Other income (expense):
Interest expense	(2,305)	(1,016)	(5,209)	(2,852)
Gain on sale of operations, net	176	0	311	6,385
Other (expense) income, net	(2,618)	(1,133)	(24,919)	12,029
Total other (expense) income, net	(4,747)	(2,149)	(29,817)	15,562
Income from continuing operations before income tax expense	36,605	29,207	157,939	106,624
Income tax expense	9,131	7,512	41,074	26,100
Income from continuing operations	27,474	21,695	116,865	80,524
Loss from discontinued operations, net of tax	(4)	(4)	(13)	(17)
Net income	$ 27,470	$ 21,691	$ 116,852	$ 80,507
Basic:
Continuing operations (in dollars per share)	$ 0.53	$ 0.41	$ 2.25	$ 1.52
Discontinued operations (in dollars per share)	0	0	0	0
Net income (in dollars per share)	0.53	0.41	2.25	1.52
Diluted:
Continuing operations (in dollars per share)	0.53	0.41	2.22	1.50
Discontinued operations (in dollars per share)	0	0	0	0
Net income (in dollars per share)	$ 0.53	$ 0.41	$ 2.22	$ 1.50
Basic weighted average shares outstanding (in shares)	51,457	52,425	51,827	52,885
Diluted weighted average shares outstanding (in shares)	52,238	53,226	52,720	53,796
Comprehensive income:
Net income	$ 27,470	$ 21,691	$ 116,852	$ 80,507
Other comprehensive income, net of tax	2,179	159	4,584	1,071
Comprehensive income	$ 29,649	$ 21,850	$ 121,436	$ 81,578

XML

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Restricted Stock Units and Awards	Performance share units	Common Stock	Common Stock Restricted Stock Units and Awards	Common Stock Performance share units	Treasury Shares	Additional Paid-In Capital	Additional Paid-In Capital Restricted Stock Units and Awards	Additional Paid-In Capital Performance share units	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Common stock, beginning balance (in shares) at Dec. 31, 2020				134,144
Treasury stock, beginning balance (in shares) at Dec. 31, 2020							80,045
Beginning balance at Dec. 31, 2020	$ 702,620			$ 1,341			$ (595,297)	$ 740,970			$ 557,875	$ (2,269)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	80,507										80,507
Other comprehensive income	1,071											1,071
Share repurchases (in shares)							2,686
Share repurchases	(84,883)						$ (84,883)
Indirect repurchase of shares for minimum tax withholding (in shares)							92
Indirect repurchase of shares for minimum tax withholding	(3,037)						$ (3,037)
Restricted stock units and awards and Performance share units (in shares)				80
Restricted stock units and awards and Performance share units	0			$ 1				(1)
Stock options exercised (in shares)				635
Stock options exercised	7,143			$ 6				7,137
Stock-based compensation	8,359							8,359
Business acquisitions (in shares)				274
Business acquisitions	8,867			$ 3				8,864
Common stock, ending balance (in shares) at Sep. 30, 2021				135,133
Treasury stock, ending balance (in shares) at Sep. 30, 2021							82,823
Ending balance at Sep. 30, 2021	720,647			$ 1,351			$ (683,217)	765,329			638,382	(1,198)
Common stock, beginning balance (in shares) at Jun. 30, 2021				134,892
Treasury stock, beginning balance (in shares) at Jun. 30, 2021							82,173
Beginning balance at Jun. 30, 2021	712,332			$ 1,349			$ (661,772)	757,421			616,691	(1,357)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	21,691										21,691
Other comprehensive income	159											159
Share repurchases (in shares)							650
Share repurchases	(21,445)						$ (21,445)
Stock options exercised (in shares)				142
Stock options exercised	1,695			$ 1				1,694
Stock-based compensation	2,905							2,905
Business acquisitions (in shares)				99
Business acquisitions	3,310			$ 1				3,309
Common stock, ending balance (in shares) at Sep. 30, 2021				135,133
Treasury stock, ending balance (in shares) at Sep. 30, 2021							82,823
Ending balance at Sep. 30, 2021	720,647			$ 1,351			$ (683,217)	765,329			638,382	(1,198)
Common stock, beginning balance (in shares) at Dec. 31, 2021				135,187
Treasury stock, beginning balance (in shares) at Dec. 31, 2021							83,149
Beginning balance at Dec. 31, 2021	704,548			$ 1,352			$ (694,716)	770,117			628,762	(967)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	116,852										116,852
Other comprehensive income	4,584											4,584
Share repurchases (in shares)							1,628
Share repurchases	(67,976)						$ (67,976)
Indirect repurchase of shares for minimum tax withholding (in shares)							188
Indirect repurchase of shares for minimum tax withholding	$ (7,289)						$ (7,289)
Restricted stock units and awards and Performance share units (in shares)					120	211
Restricted stock units and awards and Performance share units		$ 0	$ 0		$ 1	$ 2			$ (1)	$ (2)
Stock options exercised (in shares)	541			541
Stock options exercised	$ 7,994			$ 5				7,989
Stock-based compensation	11,987							11,987
Business acquisitions (in shares)				87
Business acquisitions	3,425			$ 1				3,424
Common stock, ending balance (in shares) at Sep. 30, 2022				136,146
Treasury stock, ending balance (in shares) at Sep. 30, 2022							84,965
Ending balance at Sep. 30, 2022	774,125			$ 1,361			$ (769,981)	793,514			745,614	3,617
Common stock, beginning balance (in shares) at Jun. 30, 2022				135,823
Treasury stock, beginning balance (in shares) at Jun. 30, 2022							84,221
Beginning balance at Jun. 30, 2022	764,523			$ 1,358			$ (737,559)	781,142			718,144	1,438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	27,470										27,470
Other comprehensive income	2,179											2,179
Share repurchases (in shares)							744
Share repurchases	(32,422)						$ (32,422)
Restricted stock units and awards and Performance share units (in shares)					1
Stock options exercised (in shares)				254
Stock options exercised	4,098			$ 2				4,096
Stock-based compensation	5,559							5,559
Business acquisitions (in shares)				68
Business acquisitions	2,718			$ 1				2,717
Common stock, ending balance (in shares) at Sep. 30, 2022				136,146
Treasury stock, ending balance (in shares) at Sep. 30, 2022							84,965
Ending balance at Sep. 30, 2022	$ 774,125			$ 1,361			$ (769,981)	$ 793,514			$ 745,614	$ 3,617

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income	$ 116,852	$ 80,507
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	24,707	19,921
Gain on sale of operations, net	(311)	(6,385)
Bad debt expense, net of recoveries	1,295	562
Adjustment to contingent earnout liability	1,917	1,599
Stock-based compensation expense	11,987	8,359
Deferred income taxes	5,690	7,141
Other, net	(2,083)	(373)
Changes in assets and liabilities, net of acquisitions and divestitures:
Accounts receivable, net	(125,700)	(66,017)
Other assets	(2,610)	53
Accounts payable	6,203	12,126
Income taxes payable	12,709	5,245
Accrued personnel costs	18,863	15,329
Other liabilities	(9,447)	2,897
Operating cash flows provided by continuing operations	60,072	80,964
Operating cash flows used in discontinued operations	(13)	(18)
Net cash provided by operating activities	60,059	80,946
Cash flows from investing activities:
Business acquisitions and purchases of client lists, net of cash acquired	(79,289)	(66,155)
Purchases of client fund investments	(19,771)	(13,050)
Proceeds from the sales and maturities of client fund investments	11,500	10,800
Proceeds from sales of divested operations	2,906	9,785
Change in funds held for clients	(171)	(5,708)
Additions to property and equipment	(6,030)	(6,451)
Other, net	(4,695)	51
Net cash used in investing activities	(95,550)	(70,728)
Cash flows from financing activities:
Proceeds from bank debt	655,500	680,400
Payment of bank debt	(539,700)	(598,200)
Payment for acquisition of treasury stock	(65,976)	(84,950)
Indirect repurchase of shares for minimum tax withholding	(7,289)	(3,037)
Changes in client funds obligations	(30,024)	8,375
Proceeds from exercise of stock options	7,994	7,143
Payment of contingent consideration for acquisitions	(12,408)	(7,883)
Other, net	(2,072)	(170)
Net cash provided by financing activities	6,025	1,678
Net (decrease) increase in cash, cash equivalents and restricted cash	(29,466)	11,896
Cash, cash equivalents and restricted cash at beginning of year	150,474	170,335
Cash, cash equivalents and restricted cash at end of period	121,008	182,231
Reconciliation of cash, cash equivalents and restricted cash to the   Condensed Consolidated Balance Sheets:
Cash and cash equivalents	2,040	2,749
Restricted cash	39,555	37,320
Cash equivalents included in funds held for clients	79,413	142,162
Total cash, cash equivalents and restricted cash	$ 121,008	$ 182,231

XML

Summary of Significant Accounting Policies

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Selected Terms Used in Notes to the Condensed Consolidated Financial Statements

ASA – Administrative Service Agreement

ASC – Accounting Standards Codification

ASU – Accounting Standards Update

CPA firm – Certified Public Accounting firm

FASB – The Financial Accounting Standards Board

GAAP – United States Generally Accepted Accounting Principles

SOFR – Secured Overnight Financing Rate

LIBOR – London Interbank Offered Rate

SEC – United States Securities and Exchange Commission

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements: The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2022.

Use of Estimates: The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In 2021, CBIZ formed a grantor trust (the “Trust”) with Wilmington Savings Funds Society, FSB, a Federal savings bank, serving as trustee. The Trust holds the majority of the funds provided by CBIZ’s clients for payroll processing pending remittance to employees of those clients, tax authorities, and

other payees. CBIZ is the sole beneficial owner of the Trust. The Trust is considered a variable interest entity in accordance with Accounting Standards Codification 810, Consolidation. CBIZ has both the power to direct the activities that most significantly impact the economic performance of the Trust (including the power to make all investment decisions for the Trust) and the right to receive benefits that could potentially be significant to the Trust (in the form of investment returns). As a result, CBIZ consolidates the Trust in its unaudited condensed consolidated financial statements.

XML

New Accounting Pronouncements

9 Months Ended

Sep. 30, 2022

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements

NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Adopted in 2022

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship.

On May 4, 2022, we entered into a Second Amended and Restated Credit Agreement (the "2022 credit facility" or the "credit facility"), by and among CBIZ Operations, Inc. ("CBIZ Operations"), and Bank of America, N.A., as administrative agent, and other financial institutions. The 2022 credit facility amends the Amended and Restated Credit Agreement, dated as of April 3, 2018 (the "2018 credit facility"). Among other things, the 2022 Credit Facility amended the base interest rate from LIBOR to Term SOFR. Consequently, we amended the interest rate swap agreements with respect to the existing swaps. Effective May 16, 2022, the scheduled reset date, the interest rate of the swaps were set to one-month Term SOFR to align the swaps to Term SOFR in the 2022 credit facility. No other terms under the swap agreements were amended. As a result, we early adopted ASC Topic 848, Reference Rate Reform. This adoption had immaterial impact on our consolidated financial statements. Refer to Note 4, Debt and Financing Arrangements and Note 6, Financial Instruments, for further discussion of the transaction.

XML

Accounts Receivable, Net

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Accounts Receivable, Net

ACCOUNTS RECEIVABLE, NETAccounts receivable, less allowance for doubtful accounts, reflects the net realizable value of receivables and approximates fair value. Unbilled revenue is recorded at estimated net realizable value. Assessing the collectability of the receivables (billed and unbilled) requires management judgment based on a combination of factors, including but not limited to, an evaluation of our historical incurred loss experience, credit-worthiness of our clients, age of the trade receivable balance, current economic

conditions that may affect a client’s ability to pay, and reasonable and supportable forecasts. Receivables are charged-off against the allowance when the balance is deemed uncollectible.

Accounts receivable, net, at September 30, 2022 and December 31, 2021 was as follows (in thousands):

	September 30, 2022		December 31, 2021
Trade accounts receivable	$	252,251	$	190,710
Unbilled revenue, at net realizable value	167,083		67,616
Total accounts receivable	419,334		258,326
Allowance for doubtful accounts	(20,364)		(16,158)
Accounts receivable, net	$	398,970	$	242,168

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2022 and twelve months ended December 31, 2021 are as follows (in thousands):

	September 30, 2022		December 31, 2021
Balance at beginning of period	$	(16,158)	$	(14,894)
Provision	(9,796)		(9,422)
Charge-offs, net of recoveries	5,590		8,158
Allowance for doubtful accounts	$	(20,364)	$	(16,158)

XML

Debt and Financing Arrangements

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Debt and Financing Arrangements

DEBT AND FINANCING ARRANGEMENTS

On May 4, 2022, we entered into the 2022 credit facility, which amends the 2018 credit facility.

The 2022 credit facility increased our borrowing capacity from $400 million to $600 million, which provides us with the capital necessary to meet our working capital needs as well as the flexibility to continue with our strategic initiatives, including business acquisitions and share repurchases. Other important key terms of the 2022 credit facility include: (i) an accordion feature that permits lenders to extend an additional $200 million at later date; (ii) no change in pricing from the 2018 credit facility; (iii) upsizing of baskets and various sublimits to reflect the increased size of the Company's business; (iv) a swing line facility increase from $25 million to $50 million, which provides for same-day funds to cover daily liquidity needs; and (v) base interest rate amended from LIBOR to Term SOFR. The 2022 credit facility extends the maturity date from 2023 to 2027.

In connection with our 2022 credit facility, we incurred approximately $2.1 million of financing costs during the second quarter of 2022. The financing costs are deferred and reported as a reduction of debt on the accompanying unaudited Condensed Consolidated Balance Sheets, are included as a component of cash flow from financing activities on the accompanying unaudited Condensed Consolidated Statements of Cash Flows, and are being amortized as interest expense over the term of the 2022 credit facility. In addition, we wrote-off approximately $41 thousand of unamortized deferred cost associated with the 2018 credit facility as additional interest expense in the second quarter of 2022.

The balance outstanding under the 2022 credit facility was $271.1 million at September 30, 2022. The balance outstanding under the 2018 credit facility was $155.3 million at December 31, 2021. The combined effective interest rates under the 2018 and 2022 credit facilities, including the impact of interest rate swaps associated with those credit facilities, were as follows:

	Nine Months Ended September 30,
	2022	2021
Weighted average rates	2.29%	1.89%
Range of effective rates	1.08% - 4.18%	1.06% - 3.64%

We had approximately $310.9 million of available funds under the 2022 credit facility at September 30, 2022, net of outstanding letters of credit of $5.7 million. Available funds under the credit facility are based on a multiple of earnings before interest, taxes, depreciation and amortization as defined in the credit facility, and are reduced by letters of credit, other indebtedness and outstanding borrowings under the credit facility. Under the 2022 credit facility, loans are charged an interest rate consisting of a base rate or Term SOFR rate plus an applicable margin, letters of credit are charged based on the same applicable margin, and a commitment fee is charged on the unused portion of the credit facility.

The 2022 credit facility contains certain restrictive covenants customary for facilities of this type, including restrictions on indebtedness, liens or other encumbrances, making certain payments, investments, or to sell or otherwise dispose of a substantial portion of assets, or to merge or consolidate with an unaffiliated entity. The 2022 credit facility also limits our ability to make dividend payments. Historically, we have not paid cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable future. Our Board of Directors has discretion over the payment and level of dividends on common stock, subject to the limitations of the credit facility and applicable law. The credit facility contains a provision that, in the event of a defined change in control, the credit facility may be terminated. In addition, the 2022 credit facility contains financial covenants that require us to meet certain requirements with respect to (i) a total leverage ratio and (ii) minimum interest coverage ratio which may limit our ability to borrow up to the total commitment amount. As of September 30, 2022, we are in compliance with all covenants.

Other Line of Credit - We have an unsecured $20.0 million line of credit by and among CBIZ Benefits and Insurance, Inc. and Huntington National Bank. We utilize this line to support our short-term funding requirements of payroll client fund obligations due to the investment of client funds, rather than liquidating client funds that have already been invested in available-for-sale securities. The line of credit, which was renewed on August 1, 2022 and will terminate on August 3, 2023, did not have a balance outstanding at September 30, 2022.

Interest Expense - Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2022		2021
Credit facilities	$	2,301	$	1,010
Other line of credit	4		—
Other	—		6
Total	$	2,305	$	1,016

	Nine Months Ended September 30,
	2022		2021
Credit facilities	$	5,204	$	2,833
Other line of credit	5		—
Other	—		19
Total	$	5,209	$	2,852

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

Letters of Credit and Guarantees - We provide letters of credit to landlords (lessors) of our leased premises in lieu of cash security deposits, which totaled $5.7 million and $3.4 million at September 30, 2022 and December 31, 2021, respectively. In addition, we provide license bonds to various state agencies to meet certain licensing requirements. The amount of license bonds outstanding was $2.3 million and $2.3 million at September 30, 2022 and December 31, 2021, respectively.

Legal Proceedings - On December 19, 2016, CBIZ Operations was named as a defendant in a lawsuit filed by Zotec Partners, LLC (“Zotec”) in the Marion County Indiana Superior Court. After various amendments, the lawsuit asserts claims under Indiana law for securities, statutory and common law fraud or deception, unjust enrichment, breach of contract, and vicarious liability against CBIZ Operations and a former employee of CBIZ MMP in connection with the sale of the CBIZ MMP medical billing practice to Zotec. The plaintiff claims that CBIZ Operations had a duty to disclose the fact,

unknown to employees of CBIZ Operations at the time of the transaction, that the former employee had a financial arrangement with a Zotec vendor at the time CBIZ Operations sold CBIZ MMP to Zotec. The plaintiff is seeking damages of up to $177.0 million out of the $200.0 million transaction price. Trial was held in October 2021. The jury found in favor of CBIZ on all fraud, contract and other claims before it. Zotec’s remaining claim for Indiana statutory securities fraud and CBIZ’s counterclaim for breach of contract against Zotec will be addressed by the trial Judge at a later date.In addition to the item disclosed above, the Company is, from time to time, subject to claims and lawsuits arising in the ordinary course of business. We cannot predict the outcome of all such matters or estimate the possible loss, if any. Although the proceedings are subject to uncertainties in the litigation process and the ultimate disposition of these proceedings is not presently determinable, we intend to vigorously defend these matters.

XML

Financial Instruments

9 Months Ended

Sep. 30, 2022

Investments, All Other Investments [Abstract]

Financial Instruments

FINANCIAL INSTRUMENTS

Available-For-Sale Debt Securities - In connection with certain services provided by our payroll operations, we collect funds from our clients’ accounts in advance of paying client obligations. These funds held for clients are segregated and invested in accordance with our investment policy, which requires all investments carry an investment grade rating at the time of initial investment. These investments, primarily consisting of corporate and municipal bonds, are classified as available-for-sale and are included in the “Funds held for clients” line item on the accompanying unaudited Condensed Consolidated Balance Sheets. The par value of these investments totaled $45.3 million and $37.0 million at September 30, 2022 and December 31, 2021, respectively, and had maturity or callable dates ranging from October 2022 through November 2025.

At September 30, 2022, unrealized losses on the securities were not material and have not been recognized as a credit loss because the bonds are investment grade quality and management is not required or does not intend to sell prior to an expected recovery in value. The bond issuers continue to make timely principal and interest payments.

The following table summarizes activities related to these investments for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021 (in thousands):

	Nine Months Ended September 30, 2022		Twelve Months Ended December 31, 2021
Fair value at beginning of period	$	38,670	$	25,708
Purchases	19,771		26,980
Redemptions	(5,630)		(6,530)
Maturities	(5,870)		(8,347)
Change in bond premium	(350)		1,517
Fair market value adjustment	(2,218)		(658)
Fair value at end of period	$	44,373	$	38,670

In addition to the available-for-sale debt securities discussed above, we also held other depository assets in the amount of $1.7 million and $1.1 million at September 30, 2022 and December 31, 2021, respectively. Those depository assets are classified as Level 1 in the fair value hierarchy.

Interest Rate Swaps - We utilize interest rate swaps to manage interest rate risk exposure associated with our floating-rate debt under our credit facility, or the forecasted acquisition of such liability. We do not purchase or hold any derivative instruments for trading or speculative purposes. Refer to the Annual Report on Form 10-K for the year ended December 31, 2021 for further discussion on our interest rate swaps.

As a result of the 2022 credit facility, CBIZ amended the interest rate swap agreements with respect to the existing swaps. Effective May 16, 2022, the scheduled reset date, the interest rate of the swaps are set to one-month Term SOFR to align the swaps to Term SOFR in the 2022 credit facility as a result of reference rate reform. No other terms under the swap agreements were amended.

During the third quarter of 2022, we entered into a new 5-year interest rate swap with a notional value of $20 million and fixed rate of 2.45%

Under the terms of the interest rate swaps, we pay interest at a fixed rate of interest plus applicable margin as stated in the amended agreements, and receive interest that varies with the one-month Term SOFR.

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying unaudited Condensed Consolidated Balance Sheets at September 30, 2022 and December 31, 2021 (amounts in thousands):

	September 30, 2022
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	15,000	2.571	%	6/1/2023	$	130	Other current asset
Interest rate swap	$	50,000	0.834	%	4/14/2025	$	3,820	Other non-current asset
Interest rate swap	$	30,000	1.186	%	12/14/2026	$	3,020	Other non-current asset
Interest rate swap	$	20,000	2.450	%	8/14/2027	$	1,147	Other non-current asset

	December 31, 2021
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	1.770	%	5/14/2022	$	(120)	Other current liability
Interest rate swap	$	15,000	2.640	%	6/1/2023	$	(432)	Other non-current liability
Interest rate swap	$	50,000	0.885	%	4/14/2025	$	405	Other non-current asset
Interest rate swap	$	30,000	1.249	%	12/14/2026	$	(64)	Other non-current liability

Refer to Note 7, Fair Value Measurements, for additional disclosures regarding fair value measurements.

The following table summarizes the effects of the interest rate swaps on the accompanying unaudited Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Gain Recognized in AOCI, net of tax				Gain (Loss) Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	2,815	$	66	$	220	$	(285)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	6,009	$	718	$	(278)	$	(850)

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

The following table summarizes our assets and (liabilities) at September 30, 2022 and December 31, 2021, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2022		December 31, 2021
Deferred compensation plan assets	1	$	111,060	$	136,321
Available-for-sale debt securities	1	44,373		38,670
Other depository assets	1	1,665		1,144
Deferred compensation plan liabilities	1	(111,060)		(136,321)
Interest rate swaps	2	8,117		(211)
Contingent purchase price liabilities	3	(141,208)		(79,139)

During the nine months ended September 30, 2022 and 2021, there were no transfers between the valuation hierarchy Levels 1, 2 and 3. The following table summarizes the change in Level 3 fair values

of our contingent purchase price liabilities for the nine months ended September 30, 2022 and 2021 (pre-tax basis) (in thousands):

	2022		2021
Beginning balance – January 1	$	(79,139)	$	(54,391)
Additions from business acquisitions	(74,199)		(38,149)
Settlement of contingent purchase price liabilities	14,047		9,511
Change in fair value of contingencies	461		(336)
Change in net present value of contingencies	(2,378)		(1,263)
Ending balance – September 30	$	(141,208)	$	(84,628)

Contingent purchase price liabilities result from our business acquisitions and are recorded at fair value at the time of acquisition and are presented as “Contingent purchase price liabilities — current” and “Contingent purchase price liabilities — non-current” in the accompanying unaudited Condensed Consolidated Balance Sheets. We estimate the fair value of our contingent purchase price liabilities using a probability-weighted discounted cash flow model. This fair value measure is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Fair value measurements characterized within Level 3 of the fair value hierarchy are measured based on unobservable inputs that are supported by little or no market activity and reflect our own assumptions in measuring fair value.

We probability weight risk-adjusted estimates of future performance of acquired businesses, then calculate the contingent purchase price based on the estimates and discount them to present value representing management’s best estimate of fair value. The fair value of the contingent purchase price liabilities is reassessed quarterly based on assumptions provided by practice group leaders and business unit controllers together with our corporate finance department. Any change in the fair value estimate is recorded in the earnings of that period. Refer to Note 11, Business Combinations, for further discussion of our acquisitions and contingent purchase price liabilities.

The carrying amounts of our cash and cash equivalents, accounts receivable and accounts payable approximate fair value because of the short maturity of these instruments, and the carrying value of bank debt approximates fair value as the interest rate on the bank debt is variable and approximates current market rates. As a result, the fair value measurement of our bank debt is considered to be Level 2 under the fair value hierarchy.

XML

Other Comprehensive Income

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Other Comprehensive Income

OTHER COMPREHENSIVE INCOME

The following table is a summary of other comprehensive income and discloses the tax impact of each component of other comprehensive income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(457)	$	(116)	$	(1,614)	$	(274)
Net unrealized gain on interest rate swaps, net of income taxes (2)	2,647		281		6,218		1,359
Foreign currency translation	(11)		(6)		(20)		(14)
Total other comprehensive income	$	2,179	$	159	$	4,584	$	1,071

(1)Net of income tax benefit of $171 and income tax benefit of $44 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax benefit of $604 and income tax benefit of $103 for the nine months ended September 30, 2022 and 2021, respectively.

(2)Net of income tax expense of $863 and income tax expense of $90 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax expense of $2,041 and income tax expense of $436 for the nine months ended September 30, 2022 and 2021, respectively.

XML

Employee Stock Plans

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Employee Stock Plans

EMPLOYEE STOCK PLANS

The 2019 Stock Omnibus Incentive Plan (the “2019 Plan”), which expires in 2029, permits the grant of various forms of stock-based awards. The terms and vesting schedules for the stock-based awards vary by type and date of grant. A maximum of 3.1 million stock options, restricted stock or other stock-based compensation awards may be granted. Shares subject to award under the 2019 Plan may be either authorized but unissued shares of our common stock or treasury shares. Refer to the Annual Report on Form 10-K for the year ended December 31, 2021 for further discussion on the 2019 Plan.

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Stock options	$	—	$	581	$	248	$	1,114
Restricted stock units and awards	1,188		1,388		4,015		4,214
Performance share units	4,371		936		7,724		3,031
Total stock-based compensation expense	$	5,559	$	2,905	$	11,987	$	8,359

Stock Options and Restricted Stock Units and Awards – The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2022 (in thousands, except per share data):

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,223	$	17.71	389	$	25.07
Granted	—	$	—	130	$	38.53
Exercised or released	(541)	$	14.78	(238)	$	23.47
Expired or canceled	—	$	—	(4)	$	34.04
Outstanding at September 30, 2022	682	$	20.04	277	$	32.62
Exercisable at September 30, 2022	682	$	20.04

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

Performance Share Units (“PSUs”) – PSUs are earned based on our financial performance over a contractual term of three years and the associated expense is recognized over that period based on the fair value of the award. A three-year cliff vesting schedule of the PSUs is dependent upon the Company’s performance relative to pre-established goals based on an earnings per share target (weighted 70%) and total growth in revenue (weighted 30%). The fair value of PSUs is calculated using the market value of a share of our common stock on the date of grant. For performance achieved above specified levels, the recipient may earn additional shares of stock, not to exceed 200% of the number of PSUs initially granted.

The following table presents our PSU award activity during the nine months ended September 30, 2022 (in thousands, except per share data):

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	473	$	23.64
Granted	103	$	38.15
Vested	(211)	$	19.82
Adjustments for performance results (2)	82	$	25.75
Canceled	(5)	$	33.21
Outstanding at September 30, 2022	442	$	29.12

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

(2)Represents the change in the number of performance awards earned based on performance achievement for the performance period.

XML

Earnings Per Share

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Earnings Per Share

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Income from continuing operations	$	27,474	$	21,695	$	116,865	$	80,524
Denominator:
Basic
Weighted average common shares outstanding	51,457		52,425		51,827		52,885
Diluted
Stock options (1)	434		609		523		692
Restricted stock units and awards (1)	118		155		141		182
Performance share units	205		—		205		—
Contingent shares (2)	24		37		24		37
Diluted weighted average common shares    outstanding (3)	52,238		53,226		52,720		53,796
Basic earnings per share from continuing operations	$	0.53	$	0.41	$	2.25	$	1.52
Diluted earnings per share from continuing operations	$	0.53	$	0.41	$	2.22	$	1.50

(1)A total of 72 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the nine months ended September 30, 2022, as their effect would be anti-dilutive. No stock-based awards were exclude from the calculation of diluted earnings per share for the three months ended September 30, 2022, as their effect was dilutive. A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 237 thousand performance share units for both the three and nine months ended September 30, 2022, and the denominator used in calculating diluted earnings per share did not include 447 thousand

performance share units for both the three and nine months ended September 30, 2021. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2022 and 2021.

XML

Business Combinations

9 Months Ended

Sep. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Business Combinations

BUSINESS COMBINATIONS

Business Combinations

During the nine months ended September 30, 2022, we completed the following acquisitions:

•Effective January 1, 2022, we acquired all of the non-attest assets of Marks Paneth LLP ("Marks Paneth"). Marks Paneth, based in New York City, is a provider of a full range of accounting, tax and consulting services to a wide range of industries. Marks Paneth is included as a component of our Financial Services practice group. Operating results are reported in the Financial Services practice group.

•Effective July 1, 2022, we acquired substantially all the assets of Stinnett & Associates, LLC ("Stinnett"). Stinnett, located in Tulsa, Oklahoma, is a professional advisory firm and certified Women's Business Enterprise providing internal audit, Sarbanes-Oxley compliance, cybersecurity reviews, business continuity and disaster recovery, and fraud investigations to businesses of all sizes including Fortune 1000 organizations in a variety of industries. Operating results are reported in the Financial Services practice group.

During the nine months ended September 30, 2021, we completed the following acquisitions:

•Effective January 1, 2021, we acquired substantially all the assets of Middle Market Advisory Group (“MMA”). MMA, based in Englewood, Colorado, is a provider of tax compliance and consulting services to middle market companies and family groups in the real estate, automotive, technology and SAAS, construction, and manufacturing industries. Operating results are reported in the Financial Services practice group.

•Effective April 1, 2021, we acquired substantially all the assets of Wright Retirement Services, LLC ("Wright"). Wright, located in Valdosta, Georgia, specializes in third party administration services for retirement plan sponsors. Operating results are reported in the Benefits and Insurance practice group.

•Effective May 1, 2021, we acquired substantially all of the non-attest assets of Berntson Porter & Company, PLLC ("BP"). BP, based in Bellevue, Washington is a provider of comprehensive accounting and financial consulting services including tax, forensic, economic and valuation services and transaction services to a wide range of industries with specialties including construction, real estate, hospitality, manufacturing and technology. Operating results are reported in the Financial Services practice group.

•Effective June 1, 2021, we acquired all of the issued and outstanding membership interests of Schramm Health Partners, LLC dba Optumas ("Optumas"). Optumas, based in Scottsdale, Arizona, is a provider of actuarial services to state government health care agencies to assist in the administration of Medicaid programs. Operating results are reported in the Financial Services practice group.

•Effective September 1, 2021, we acquired all of the non-attest assets of Shea Labagh Dobberstein ("SLD"). SLD, based in San Francisco, California, is a provider of professional accounting, tax and advisory services to privately held businesses, individuals and nonprofit organizations. Operating results are reported in the Financial Services practice group.

The acquisitions of Marks Paneth and Stinnett are expected to add approximately $154.5 million annualized revenue in 2022. For the nine months ended September 30, 2022, we recorded approximately $9.3 million in non-recurring transaction, retention and integration related costs associated with the Marks Paneth acquisition. Pro forma results of operations for these acquisitions have not been presented because the effects of these acquisitions were not material, either individually or in aggregate, to our total revenue, income from continuing operations, and net income for the three and nine months ended September 30, 2022 and 2021, respectively.

The following table summarizes the consideration and purchase price allocation for the acquisitions completed during the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	2022		2021
Common stock issued (number)	42		207
Common stock value	$	1,668	$	6,940
Cash paid	79,141		66,051
Recorded contingent consideration	74,199		38,148
Total recorded purchase price	$	155,008	$	111,139
Accounts receivable acquired	20,429		13,125
Fixed assets acquired	1,933		1,473
Identifiable intangible assets acquired	53,400		40,753
Operating lease right-of-use asset acquired	49,291		17,814
Other assets acquired	1,693		1,316
Operating lease liability acquired - current	(5,860)		(2,785)
Other current liabilities acquired	(1,594)		(5,735)
Operating lease liability acquired - non-current	(43,431)		(15,029)
Goodwill	79,147		60,207
Total net assets acquired	$	155,008	$	111,139
Maximum potential contingent consideration	$	77,075	$	40,126

The following table summarizes the goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Nine Months Ended September 30,
	2022				2021
	Financial Services		Benefits and Insurance Services		Financial Services		Benefits and Insurance Services
Goodwill	$	79,147	$	—	$	58,409	$	1,798
Client list	53,400		—		38,580		1,290
Other intangibles	—		—		837		46
Total	$	132,547	$	—	$	97,826	$	3,134

Goodwill is calculated as the difference between the aggregated purchase price and the fair value of the net assets acquired. Goodwill represents the value of expected future earnings and cash flows, as well as the synergies created by the integration of the new businesses within our organization, including cross-selling opportunities expected with our Financial Services practice group and the Benefits and Insurance Services practice group, to help strengthen our existing service offerings and expand our market position. Goodwill related to these acquisitions is deductible for tax purposes. Client lists from the aforementioned acquisitions have an expected life up to 10 years, and other intangibles, primarily non-compete agreements, have an expected life of 3 years. Client lists and non-compete agreements are valued using a discounted cash flow technique based on management estimates of future cash flows from such assets.

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and contingent payments made for previous business acquisitions in the three and nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net expense	$	440	$	846	$	1,917	$	1,599
Cash settlement paid	$	4,167	$	—	$	12,289	$	7,584
Shares issued (number)	26		13		45		66

Divestitures

Divested operations and assets that do not qualify for treatment as discontinued operations are recorded as “Gain on sale of operations, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. During the nine months ended September 30, 2021, we sold one business unit for $9.7 million in the Benefit and Insurance practice group and recorded a gain of $6.4 million.

In addition, during the three and nine months ended September 30, 2022, we sold one small book of business for $2.5 million in the Benefits and Insurance Services practice group and recorded a gain of $2.4 million. This gain is recorded as “Other (expense) income, net” in the accompanying Condensed Consolidated Statements of Comprehensive Income. Gain on book of business sales in the three and nine months ended September 30, 2021 was immaterial.

XML

Segment Disclosures

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Disclosures

SEGMENT DISCLOSURES

Our business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services and National Practices. The business units have been aggregated based on the following factors: similarity of the products and services provided to clients; similarity of the regulatory environment in which they operate; and similarity of economic conditions affecting long-term performance. The business units are managed along these segment lines. A general description of services provided by each practice group is provided in the table below.

Financial Services	Benefits and Insurance Services	National Practices
Accounting and Tax	Employee Benefits Consulting	Information Technology Managed Networking and Hardware Services
Financial Advisory	Payroll / Human Capital Management	Healthcare Consulting
Valuation	Property and Casualty Insurance
Risk and Advisory Services	Retirement and Investment Services
Government Healthcare Consulting

Corporate and Other - Included in Corporate and Other are operating expenses that are not directly allocated to the individual business units. These expenses primarily consist of certain health care costs, gains or losses attributable to assets held in our non-qualified deferred compensation plan, stock-based compensation, consolidation and integration charges, certain professional fees, certain advertising costs and other various expenses.

Accounting policies of the practice groups are the same as those described in Note 1, Basis of Presentation and Significant Accounting Policies, to the Annual Report on Form 10-K for the year ended December 31, 2021. Upon consolidation, intercompany accounts and transactions are eliminated, thus inter-segment revenue is not included in the measure of profit or loss for the practice groups. Performance of the practice groups is evaluated on income (loss) from continuing operations before income tax expense (benefit) excluding those costs listed above, which are reported in the “Corporate and Other”.

Segment information for the three and nine months ended September 30, 2022 and 2021 is presented below. We do not manage our assets on a segment basis, therefore segment assets are not presented belowThe following table disaggregates our revenue by source (in thousands):

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	259,998	—		—		$	259,998
Core benefits and insurance services	—		88,364		—		88,364
Non-core benefits and insurance services	—		3,703		—		3,703
Managed networking, hardware services	—		—		8,514		8,514
National practices consulting	—		—		2,683		2,683
Total revenue	$	259,998	$	92,067	$	11,197	$	363,262

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	808,052	—		—		$	808,052
Core benefits and insurance services	—		264,666		—		264,666
Non-core benefits and insurance services	—		11,595		—		11,595
Managed networking, hardware services	—		—		24,768		24,768
National practices consulting	—		—		7,855		7,855
Total revenue	$	808,052	$	276,261	$	32,623	$	1,116,936

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

Segment information for the three months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	259,998	$	92,067	$	11,197	$	—	$	363,262
Operating expenses	220,337		73,321		9,743		2,616		306,017
Gross margin	39,661		18,746		1,454		(2,616)		57,245
Corporate general and administrative expenses	—		—		—		15,893		15,893
Operating income (loss)	39,661		18,746		1,454		(18,509)		41,352
Other income (expense):
Interest expense	—		(4)		—		(2,301)		(2,305)
Gain on sale of operations, net	176		—		—		—		176
Other income (expense), net	103		2,402		8		(5,131)		(2,618)
Total other income (expense), net	279		2,398		8		(7,432)		(4,747)
Income (loss) from continuing operations before income tax expense	$	39,940	$	21,144	$	1,462	$	(25,941)	$	36,605

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

Segment information for the nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	808,052	$	276,261	$	32,623	$	—	$	1,116,936
Operating expenses (income)	639,780		220,998		29,218		(3,944)		886,052
Gross margin	168,272		55,263		3,405		3,944		230,884
Corporate general and administrative expenses	—		—		—		43,128		43,128
Operating income (loss)	168,272		55,263		3,405		(39,184)		187,756
Other income (expense):
Interest expense	—		(5)		—		(5,204)		(5,209)
Gain on sale of operations, net	311		—		—		—		311
Other income (expense), net	274		2,366		9		(27,568)		(24,919)
Total other income (expense), net	585		2,361		9		(32,772)		(29,817)
Income (loss) from continuing operations before income tax expense	$	168,857	$	57,624	$	3,414	$	(71,956)	$	157,939

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net	—		—		—		30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

XML

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSSubsequent to September 30, 2022 and up to October 26, 2022, we repurchased approximately 0.4 million shares of our common stock in the open market at a total cost of approximately $18.0 million.

XML

Summary of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

Description of Business

Description of Business: CBIZ, Inc. is a diversified services company which, acting through its subsidiaries, has been providing professional business services since 1996, primarily to small and medium-sized businesses, as well as individuals, governmental entities, and not-for-profit enterprises throughout the United States and parts of Canada. CBIZ, Inc. manages and reports its operations along three practice groups: Financial Services, Benefits and Insurance Services and National Practices. A further description of products and services offered by each of the practice groups is provided in Note 12, Segment Disclosures, to the accompanying unaudited condensed consolidated financial statements.

Basis of Consolidation

Basis of Consolidation: The accompanying unaudited condensed consolidated financial statements include the operations of CBIZ, Inc. and all of its wholly-owned subsidiaries (“CBIZ”, the “Company”, “we”, “us”, or “our”), after elimination of all intercompany balances and transactions. These unaudited condensed consolidated financial statements do not reflect the operations or accounts of variable interest entities as the impact is not material to the financial condition, results of operations or cash flows of CBIZ.

Unaudited Interim Financial Statements

Unaudited Interim Financial Statements: The unaudited condensed consolidated financial statements have been prepared in accordance with GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In the opinion of CBIZ management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial condition, results of operations, and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations to be anticipated for the full year ending December 31, 2022.

Use of Estimates

Use of Estimates: The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Changes in circumstances could cause actual results to differ materially from these estimates.

Changes in Accounting Policies

Changes in Accounting Policies: We have consistently applied the accounting policies for the periods presented as described in Note 1, Basis of Presentation and Significant Accounting Policies, to the consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

In 2021, CBIZ formed a grantor trust (the “Trust”) with Wilmington Savings Funds Society, FSB, a Federal savings bank, serving as trustee. The Trust holds the majority of the funds provided by CBIZ’s clients for payroll processing pending remittance to employees of those clients, tax authorities, and

other payees. CBIZ is the sole beneficial owner of the Trust. The Trust is considered a variable interest entity in accordance with Accounting Standards Codification 810, Consolidation. CBIZ has both the power to direct the activities that most significantly impact the economic performance of the Trust (including the power to make all investment decisions for the Trust) and the right to receive benefits that could potentially be significant to the Trust (in the form of investment returns). As a result, CBIZ consolidates the Trust in its unaudited condensed consolidated financial statements.

New Accounting Pronouncements

NEW ACCOUNTING PRONOUNCEMENTS

The FASB ASC is the sole source of authoritative GAAP other than the SEC issued rules and regulations that apply only to SEC registrants. The FASB issues an accounting standard to communicate changes to the FASB codification. We assess and review the impact of all accounting standards. Any accounting standards not listed below were reviewed and determined to be either not applicable or are not expected to have a material impact on the consolidated financial statements of the Company.

Accounting Standards Adopted in 2022

Reference Rate Reform: In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities through December 31, 2022.

Subsequently, in January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which provides optional temporary guidance for entities transitioning away from the LIBOR and other interbank offered rates to new reference rates so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions within Topic 848. This ASU clarifies that the derivative instruments affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions provided in Topic 848. ASU 2021-01 is effective immediately for all entities. Entities may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. The amendments provided in this ASU do not apply to contract modifications made, as well as new hedging relationships entered into, after December 31, 2022, and to existing hedging relationships evaluated for effectiveness for periods after December 31, 2022, except for certain hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship.

On May 4, 2022, we entered into a Second Amended and Restated Credit Agreement (the "2022 credit facility" or the "credit facility"), by and among CBIZ Operations, Inc. ("CBIZ Operations"), and Bank of America, N.A., as administrative agent, and other financial institutions. The 2022 credit facility amends the Amended and Restated Credit Agreement, dated as of April 3, 2018 (the "2018 credit facility"). Among other things, the 2022 Credit Facility amended the base interest rate from LIBOR to Term SOFR. Consequently, we amended the interest rate swap agreements with respect to the existing swaps. Effective May 16, 2022, the scheduled reset date, the interest rate of the swaps were set to one-month Term SOFR to align the swaps to Term SOFR in the 2022 credit facility. No other terms under the swap agreements were amended. As a result, we early adopted ASC Topic 848, Reference Rate Reform. This adoption had immaterial impact on our consolidated financial statements. Refer to Note 4, Debt and Financing Arrangements and Note 6, Financial Instruments, for further discussion of the transaction.

XML

Accounts Receivable, Net (Tables)

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Schedule of Accounts Receivable, Net

Accounts receivable, net, at September 30, 2022 and December 31, 2021 was as follows (in thousands):

	September 30, 2022		December 31, 2021
Trade accounts receivable	$	252,251	$	190,710
Unbilled revenue, at net realizable value	167,083		67,616
Total accounts receivable	419,334		258,326
Allowance for doubtful accounts	(20,364)		(16,158)
Accounts receivable, net	$	398,970	$	242,168

Schedule of Changes in the Allowance for Doubtful Accounts on Accounts Receivable

Changes to the allowance for doubtful accounts for the nine months ended September 30, 2022 and twelve months ended December 31, 2021 are as follows (in thousands):

	September 30, 2022		December 31, 2021
Balance at beginning of period	$	(16,158)	$	(14,894)
Provision	(9,796)		(9,422)
Charge-offs, net of recoveries	5,590		8,158
Allowance for doubtful accounts	$	(20,364)	$	(16,158)

XML

Debt and Financing Arrangements (Tables)

9 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Summary of Unsecured Credit Facility

The combined effective interest rates under the 2018 and 2022 credit facilities, including the impact of interest rate swaps associated with those credit facilities, were as follows:

	Nine Months Ended September 30,
	2022	2021
Weighted average rates	2.29%	1.89%
Range of effective rates	1.08% - 4.18%	1.06% - 3.64%

Summary of Recognized Interest Expense

Interest expense, including amortization of deferred financing costs, commitment fees, line of credit fees, and other applicable bank charges, was as follows (in thousands):

	Three Months Ended September 30,
	2022		2021
Credit facilities	$	2,301	$	1,010
Other line of credit	4		—
Other	—		6
Total	$	2,305	$	1,016

	Nine Months Ended September 30,
	2022		2021
Credit facilities	$	5,204	$	2,833
Other line of credit	5		—
Other	—		19
Total	$	5,209	$	2,852

XML

Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Investments, All Other Investments [Abstract]

Summary of Investments

The following table summarizes activities related to these investments for the nine months ended September 30, 2022 and the twelve months ended December 31, 2021 (in thousands):

	Nine Months Ended September 30, 2022		Twelve Months Ended December 31, 2021
Fair value at beginning of period	$	38,670	$	25,708
Purchases	19,771		26,980
Redemptions	(5,630)		(6,530)
Maturities	(5,870)		(8,347)
Change in bond premium	(350)		1,517
Fair market value adjustment	(2,218)		(658)
Fair value at end of period	$	44,373	$	38,670

Summary of Outstanding Interest Rate Swaps

The following table summarizes our outstanding interest rate swaps and their classification in the accompanying unaudited Condensed Consolidated Balance Sheets at September 30, 2022 and December 31, 2021 (amounts in thousands):

	September 30, 2022
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	15,000	2.571	%	6/1/2023	$	130	Other current asset
Interest rate swap	$	50,000	0.834	%	4/14/2025	$	3,820	Other non-current asset
Interest rate swap	$	30,000	1.186	%	12/14/2026	$	3,020	Other non-current asset
Interest rate swap	$	20,000	2.450	%	8/14/2027	$	1,147	Other non-current asset

	December 31, 2021
	Notional Amount		Fixed Rate		Expiration	Fair Value		Balance Sheet Location
Interest rate swap	$	20,000	1.770	%	5/14/2022	$	(120)	Other current liability
Interest rate swap	$	15,000	2.640	%	6/1/2023	$	(432)	Other non-current liability
Interest rate swap	$	50,000	0.885	%	4/14/2025	$	405	Other non-current asset
Interest rate swap	$	30,000	1.249	%	12/14/2026	$	(64)	Other non-current liability

Summary of Effects of Interest Rate Swap

The following table summarizes the effects of the interest rate swaps on the accompanying unaudited Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Gain Recognized in AOCI, net of tax				Gain (Loss) Reclassified from AOCL into Expense
	Three Months Ended September 30,				Three Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	2,815	$	66	$	220	$	(285)

	Nine Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Interest rate swaps	$	6,009	$	718	$	(278)	$	(850)

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table summarizes our assets and (liabilities) at September 30, 2022 and December 31, 2021, respectively, that are measured at fair value on a recurring basis subsequent to initial recognition and indicates the fair value hierarchy of the valuation techniques utilized by us to determine such fair value (in thousands):

	Level	September 30, 2022		December 31, 2021
Deferred compensation plan assets	1	$	111,060	$	136,321
Available-for-sale debt securities	1	44,373		38,670
Other depository assets	1	1,665		1,144
Deferred compensation plan liabilities	1	(111,060)		(136,321)
Interest rate swaps	2	8,117		(211)
Contingent purchase price liabilities	3	(141,208)		(79,139)

Change in Level 3 Fair Values of Contingent Purchase Price Liabilities

The following table summarizes the change in Level 3 fair values

of our contingent purchase price liabilities for the nine months ended September 30, 2022 and 2021 (pre-tax basis) (in thousands):

	2022		2021
Beginning balance – January 1	$	(79,139)	$	(54,391)
Additions from business acquisitions	(74,199)		(38,149)
Settlement of contingent purchase price liabilities	14,047		9,511
Change in fair value of contingencies	461		(336)
Change in net present value of contingencies	(2,378)		(1,263)
Ending balance – September 30	$	(141,208)	$	(84,628)

XML

Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2022

Equity [Abstract]

Summary of Other Comprehensive Income and Tax Impact

The following table is a summary of other comprehensive income and discloses the tax impact of each component of other comprehensive income for the three and nine months ended September 30, 2022 and 2021 (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net unrealized loss on available-for-sale    securities, net of income taxes (1)	$	(457)	$	(116)	$	(1,614)	$	(274)
Net unrealized gain on interest rate swaps, net of income taxes (2)	2,647		281		6,218		1,359
Foreign currency translation	(11)		(6)		(20)		(14)
Total other comprehensive income	$	2,179	$	159	$	4,584	$	1,071

(1)Net of income tax benefit of $171 and income tax benefit of $44 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax benefit of $604 and income tax benefit of $103 for the nine months ended September 30, 2022 and 2021, respectively.

(2)Net of income tax expense of $863 and income tax expense of $90 for the three months ended September 30, 2022 and 2021, respectively, and net of income tax expense of $2,041 and income tax expense of $436 for the nine months ended September 30, 2022 and 2021, respectively.

XML

Employee Stock Plans (Tables)

9 Months Ended

Sep. 30, 2022

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Awards

Compensation expense for stock-based awards recognized during the three and nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Stock options	$	—	$	581	$	248	$	1,114
Restricted stock units and awards	1,188		1,388		4,015		4,214
Performance share units	4,371		936		7,724		3,031
Total stock-based compensation expense	$	5,559	$	2,905	$	11,987	$	8,359

Schedule of Stock Options, Restricted Stock Units and Awards, and Performance Share Units Award Activity

The following table presents our stock options and restricted stock units and awards activity during the nine months ended September 30, 2022 (in thousands, except per share data):

	Stock Options			Restricted Stock Units and Awards
	Number of Options	Weighted Average Exercise Price Per Share		Number of Shares	Weighted Average Grant-Date Fair Value (1)
Outstanding at beginning of year	1,223	$	17.71	389	$	25.07
Granted	—	$	—	130	$	38.53
Exercised or released	(541)	$	14.78	(238)	$	23.47
Expired or canceled	—	$	—	(4)	$	34.04
Outstanding at September 30, 2022	682	$	20.04	277	$	32.62
Exercisable at September 30, 2022	682	$	20.04

(1)Represents weighted average market value of the shares; awards are granted at no cost to the recipients.

The following table presents our PSU award activity during the nine months ended September 30, 2022 (in thousands, except per share data):

	Performance Share Units	Weighted Average Grant-Date Fair Value Per Unit (1)
Outstanding at beginning of year	473	$	23.64
Granted	103	$	38.15
Vested	(211)	$	19.82
Adjustments for performance results (2)	82	$	25.75
Canceled	(5)	$	33.21
Outstanding at September 30, 2022	442	$	29.12

(1)Represents weighted average market value of the performance share units; PSUs are granted at no cost to the recipients.

(2)Represents the change in the number of performance awards earned based on performance achievement for the performance period.

XML

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2022

Earnings Per Share [Abstract]

Computation of Basic and Diluted Earnings Per Share from Continuing Operations

The following table sets forth the computation of basic and diluted earnings per share from continuing operations for the three and nine months ended September 30, 2022 and 2021 (in thousands, except per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Numerator:
Income from continuing operations	$	27,474	$	21,695	$	116,865	$	80,524
Denominator:
Basic
Weighted average common shares outstanding	51,457		52,425		51,827		52,885
Diluted
Stock options (1)	434		609		523		692
Restricted stock units and awards (1)	118		155		141		182
Performance share units	205		—		205		—
Contingent shares (2)	24		37		24		37
Diluted weighted average common shares    outstanding (3)	52,238		53,226		52,720		53,796
Basic earnings per share from continuing operations	$	0.53	$	0.41	$	2.25	$	1.52
Diluted earnings per share from continuing operations	$	0.53	$	0.41	$	2.22	$	1.50

(1)A total of 72 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the nine months ended September 30, 2022, as their effect would be anti-dilutive. No stock-based awards were exclude from the calculation of diluted earnings per share for the three months ended September 30, 2022, as their effect was dilutive. A total of 44 thousand and 106 thousand shares of stock-based awards were excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021, respectively, as their effect would be anti-dilutive.

(2)Contingent shares represent additional shares to be issued for purchase price earned by former owners of businesses acquired by us once future considerations have been met. Refer to Note 11, Business Combinations, for further details.

(3)The denominator used in calculating diluted earnings per share did not include 237 thousand performance share units for both the three and nine months ended September 30, 2022, and the denominator used in calculating diluted earnings per share did not include 447 thousand

performance share units for both the three and nine months ended September 30, 2021. The performance conditions associated with these performance share units were not met and consequently none of these performance share units were considered as issuable for the three and nine months ended September 30, 2022 and 2021.

XML

Business Combinations (Tables)

9 Months Ended

Sep. 30, 2022

Business Combination and Asset Acquisition [Abstract]

Aggregated Consideration And Purchase Price Allocation

The following table summarizes the consideration and purchase price allocation for the acquisitions completed during the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	2022		2021
Common stock issued (number)	42		207
Common stock value	$	1,668	$	6,940
Cash paid	79,141		66,051
Recorded contingent consideration	74,199		38,148
Total recorded purchase price	$	155,008	$	111,139
Accounts receivable acquired	20,429		13,125
Fixed assets acquired	1,933		1,473
Identifiable intangible assets acquired	53,400		40,753
Operating lease right-of-use asset acquired	49,291		17,814
Other assets acquired	1,693		1,316
Operating lease liability acquired - current	(5,860)		(2,785)
Other current liabilities acquired	(1,594)		(5,735)
Operating lease liability acquired - non-current	(43,431)		(15,029)
Goodwill	79,147		60,207
Total net assets acquired	$	155,008	$	111,139
Maximum potential contingent consideration	$	77,075	$	40,126

Segment Allocation

The following table summarizes the goodwill and intangible asset amounts resulting from those acquisitions for the nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Nine Months Ended September 30,
	2022				2021
	Financial Services		Benefits and Insurance Services		Financial Services		Benefits and Insurance Services
Goodwill	$	79,147	$	—	$	58,409	$	1,798
Client list	53,400		—		38,580		1,290
Other intangibles	—		—		837		46
Total	$	132,547	$	—	$	97,826	$	3,134

Contingent Consideration

The following table summarizes the changes in contingent purchase price consideration for previous acquisitions and contingent payments made for previous business acquisitions in the three and nine months ended September 30, 2022 and 2021, respectively (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2022		2021		2022		2021
Net expense	$	440	$	846	$	1,917	$	1,599
Cash settlement paid	$	4,167	$	—	$	12,289	$	7,584
Shares issued (number)	26		13		45		66

XML

Segment Disclosures (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Summary of Disaggregation of Revenue by Source

The following table disaggregates our revenue by source (in thousands):

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	259,998	—		—		$	259,998
Core benefits and insurance services	—		88,364		—		88,364
Non-core benefits and insurance services	—		3,703		—		3,703
Managed networking, hardware services	—		—		8,514		8,514
National practices consulting	—		—		2,683		2,683
Total revenue	$	259,998	$	92,067	$	11,197	$	363,262

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	187,232	—		—		$	187,232
Core benefits and insurance services	—		83,009		—		83,009
Non-core benefits and insurance services	—		2,788		—		2,788
Managed networking, hardware services	—		—		7,088		7,088
National practices consulting	—		—		2,602		2,602
Total revenue	$	187,232	$	85,797	$	9,690	$	282,719

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	808,052	—		—		$	808,052
Core benefits and insurance services	—		264,666		—		264,666
Non-core benefits and insurance services	—		11,595		—		11,595
Managed networking, hardware services	—		—		24,768		24,768
National practices consulting	—		—		7,855		7,855
Total revenue	$	808,052	$	276,261	$	32,623	$	1,116,936

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Consolidated
Accounting, tax, advisory and consulting	$	577,970	—		—		$	577,970
Core benefits and insurance services	—		246,367		—		246,367
Non-core benefits and insurance services	—		9,289		—		9,289
Managed networking, hardware services	—		—		20,952		20,952
National practices consulting	—		—		7,519		7,519
Total revenue	$	577,970	$	255,656	$	28,471	$	862,097

Summary of Segment Information

Segment information for the three months ended September 30, 2022 and 2021 was as follows (in thousands):

	Three Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	259,998	$	92,067	$	11,197	$	—	$	363,262
Operating expenses	220,337		73,321		9,743		2,616		306,017
Gross margin	39,661		18,746		1,454		(2,616)		57,245
Corporate general and administrative expenses	—		—		—		15,893		15,893
Operating income (loss)	39,661		18,746		1,454		(18,509)		41,352
Other income (expense):
Interest expense	—		(4)		—		(2,301)		(2,305)
Gain on sale of operations, net	176		—		—		—		176
Other income (expense), net	103		2,402		8		(5,131)		(2,618)
Total other income (expense), net	279		2,398		8		(7,432)		(4,747)
Income (loss) from continuing operations before income tax expense	$	39,940	$	21,144	$	1,462	$	(25,941)	$	36,605

	Three Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	187,232	$	85,797	$	9,690	$	—	$	282,719
Operating expenses	156,178		69,039		8,514		4,597		238,328
Gross margin	31,054		16,758		1,176		(4,597)		44,391
Corporate general and administrative expenses	—		—		—		13,035		13,035
Operating income (loss)	31,054		16,758		1,176		(17,632)		31,356
Other income (expense):
Interest expense	—		—		—		(1,016)		(1,016)
Other income (expense), net	18		(9)		1		(1,143)		(1,133)
Total other income (expense), net	18		(9)		1		(2,159)		(2,149)
Income (loss) from continuing operations before income tax expense	$	31,072	$	16,749	$	1,177	$	(19,791)	$	29,207

Segment information for the nine months ended September 30, 2022 and 2021 was as follows (in thousands):

	Nine Months Ended September 30, 2022
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	808,052	$	276,261	$	32,623	$	—	$	1,116,936
Operating expenses (income)	639,780		220,998		29,218		(3,944)		886,052
Gross margin	168,272		55,263		3,405		3,944		230,884
Corporate general and administrative expenses	—		—		—		43,128		43,128
Operating income (loss)	168,272		55,263		3,405		(39,184)		187,756
Other income (expense):
Interest expense	—		(5)		—		(5,204)		(5,209)
Gain on sale of operations, net	311		—		—		—		311
Other income (expense), net	274		2,366		9		(27,568)		(24,919)
Total other income (expense), net	585		2,361		9		(32,772)		(29,817)
Income (loss) from continuing operations before income tax expense	$	168,857	$	57,624	$	3,414	$	(71,956)	$	157,939

	Nine Months Ended September 30, 2021
	Financial Services		Benefits and Insurance Services		National Practices		Corporate and Other		Total
Revenue	$	577,970	$	255,656	$	28,471	$	—	$	862,097
Operating expenses	448,844		203,748		25,542		21,099		699,233
Gross margin	129,126		51,908		2,929		(21,099)		162,864
Corporate general and administrative expenses	—		—		—		41,334		41,334
Legal settlement, net	—		—		—		30,468		30,468
Operating income (loss)	129,126		51,908		2,929		(92,901)		91,062
Other income (expense):
Interest expense	—		—		—		(2,852)		(2,852)
Gain on sale of operations, net	—		6,385		—		—		6,385
Other income, net	310		863		1		10,855		12,029
Total other income, net	310		7,248		1		8,003		15,562
Income (loss) from continuing operations before income tax expense	$	129,436	$	59,156	$	2,930	$	(84,898)	$	106,624

XML

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2022 practice_group
Accounting Policies [Abstract]
Number of practice groups	3

XML

Accounts Receivable, Net - Schedule of Accounts Receivables Net (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Trade accounts receivable	$ 252,251	$ 190,710
Unbilled revenue, at net realizable value	167,083	67,616
Total accounts receivable	419,334	258,326
Allowance for doubtful accounts	(20,364)	(16,158)	$ (14,894)
Accounts receivable, net	$ 398,970	$ 242,168

XML

Accounts Receivable, Net - Schedule of Changes in the Allowance for Doubtful Accounts on Accounts Receivable (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ (16,158)	$ (14,894)
Provision	(9,796)	(9,422)
Charge-offs, net of recoveries	5,590	8,158
Allowance for doubtful accounts	$ (20,364)	$ (16,158)

XML

Debt and Financing Arrangements - Additional Information (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	May 04, 2022	May 03, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Outstanding balance under applicable credit facility		$ 271,100,000			$ 155,300,000
Outstanding letters of credit		5,700,000			3,400,000
Other line of credit
Debt Instrument [Line Items]
Revolving loan commitment		20,000,000
Outstanding line of credit		0
2022 Credit Facility
Debt Instrument [Line Items]
Revolving loan commitment			$ 600,000,000	$ 400,000,000
Revolving loan, accordion feature			200,000,000
Debt issuance costs	$ 2,100,000
Outstanding balance under applicable credit facility		271,100,000
Available funds under credit facility		310,900,000
Outstanding letters of credit		$ 5,700,000
2022 Credit Facility | Swing Line Facility
Debt Instrument [Line Items]
Revolving loan commitment			$ 50,000,000	$ 25,000,000
2018 Credit Facility
Debt Instrument [Line Items]
Write off of deferred debt issuance cost	$ 41,000
Outstanding balance under applicable credit facility					$ 155,300,000

XML

Debt and Financing Arrangements - Summary of Unsecured Credit Facility (Details) - 2018 and 2022 Credit Facilities	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Weighted average rates	2.29%	1.89%
Minimum
Debt Instrument [Line Items]
Range of effective rates	1.08%	1.06%
Maximum
Debt Instrument [Line Items]
Range of effective rates	4.18%	3.64%

XML

Debt and Financing Arrangements - Summary of Recognized Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Total	$ 2,305	$ 1,016	$ 5,209	$ 2,852
Credit facilities
Debt Instrument [Line Items]
Total	2,301	1,010	5,204	2,833
Other line of credit
Debt Instrument [Line Items]
Total	4	0	5	0
Other
Debt Instrument [Line Items]
Total	$ 0	$ 6	$ 0	$ 19

XML

Commitments and Contingencies - Letters of Credit and Guarantees (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Letters of credit outstanding	$ 5.7	$ 3.4
License bonds outstanding amount	$ 2.3	$ 2.3

XML

Commitments and Contingencies - Legal Proceedings (Details) - CBIZ Operations and a former employee of CBIZ MMP $ in Millions	Dec. 19, 2016 USD ($)
Commitments And Contingencies [Line Items]
Total transaction price	$ 200.0
Maximum
Commitments And Contingencies [Line Items]
Damages sought amount	$ 177.0

XML

Financial Instruments - Additional Information (Details) - USD ($)	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Par value of available-for-sale debt securities	$ 45,300,000	$ 37,000,000
Funds held for clients	$ 125,451,000	157,909,000
Interest rate swap, August 2027 expiration | Other non-current asset
Debt Securities, Available-for-sale [Line Items]
Term of contract	5 years
Notional amount, asset	$ 20,000,000
Interest rate swap, fixed interest rate	2.45%
Certified Deposits and Other Depository Assets
Debt Securities, Available-for-sale [Line Items]
Funds held for clients	$ 1,700,000	$ 1,100,000

XML

Financial Instruments - Summary of Investments (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available for Sale [Roll Forward]
Fair value at beginning of period	$ 38,670	$ 25,708
Purchases	19,771	26,980
Redemptions	(5,630)	(6,530)
Maturities	(5,870)	(8,347)
Change in bond premium	(350)	1,517
Fair market value adjustment	(2,218)	(658)
Fair value at end of period	$ 44,373	$ 38,670

XML

Financial Instruments - Summary of Outstanding Interest Rate Swaps (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Interest rate swap, June 2023 expiration | Other current asset
Derivatives, Fair Value [Line Items]
Notional amount, asset	$ 15,000,000
Interest rate swap, fixed interest rate	2.571%
Fair value, asset	$ 130,000
Interest rate swap, June 2023 expiration | Other non-current liability
Derivatives, Fair Value [Line Items]
Notional amount, liability		$ 15,000,000
Interest rate swap, fixed interest rate		2.64%
Fair value, liability		$ (432,000)
Interest rate swap, May 2022 expiration | Other current liability
Derivatives, Fair Value [Line Items]
Notional amount, liability		$ 20,000,000
Interest rate swap, fixed interest rate		1.77%
Fair value, liability		$ (120,000)
Interest rate swap, April 2025 expiration | Other non-current asset
Derivatives, Fair Value [Line Items]
Notional amount, asset	$ 50,000,000	$ 50,000,000
Interest rate swap, fixed interest rate	0.834%	0.885%
Fair value, asset	$ 3,820,000	$ 405,000
Interest rate swap, December 2026 expiration | Other non-current asset
Derivatives, Fair Value [Line Items]
Notional amount, asset	$ 30,000,000
Interest rate swap, fixed interest rate	1.186%
Fair value, asset	$ 3,020,000
Interest rate swap, December 2026 expiration | Other non-current liability
Derivatives, Fair Value [Line Items]
Notional amount, liability		$ 30,000,000
Interest rate swap, fixed interest rate		1.249%
Fair value, liability		$ (64,000)
Interest rate swap, August 2027 expiration | Other non-current asset
Derivatives, Fair Value [Line Items]
Notional amount, asset	$ 20,000,000
Interest rate swap, fixed interest rate	2.45%
Fair value, asset	$ 1,147,000

XML

Financial Instruments - Summary of Effects of Interest Rate Swaps (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivatives, Fair Value [Line Items]
Gain Recognized in AOCI, net of tax	$ 2,647	$ 281	$ 6,218	$ 1,359
Interest rate swap
Derivatives, Fair Value [Line Items]
Gain Recognized in AOCI, net of tax	2,815	66	6,009	718
Gain (Loss) Reclassified from AOCL into Expense	$ 220	$ (285)	$ (278)	$ (850)

XML

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan assets	$ 111,060	$ 136,321
Available-for-sale debt securities	44,373	38,670	$ 25,708
Deferred compensation plan liabilities	(111,060)	(136,321)
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation plan assets	111,060	136,321
Available-for-sale debt securities	44,373	38,670
Other depository assets	1,665	1,144
Deferred compensation plan liabilities	(111,060)	(136,321)
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swaps	8,117	(211)
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent purchase price liabilities	$ (141,208)	$ (79,139)

XML

Fair Value Measurements - Additional Information (Details) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Fair Value Disclosures [Abstract]
Fair value measurements, inter-transfers between levels	$ 0	$ 0

XML

Fair Value Measurements - Change in Level 3 Fair Values of Contingent Purchase Price Liabilities (Details) - Contingent purchase price liabilities - Level 3 - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance – January 1	$ (79,139)	$ (54,391)
Additions from business acquisitions	(74,199)	(38,149)
Settlement of contingent purchase price liabilities	14,047	9,511
Change in fair value of contingencies	461	(336)
Change in net present value of contingencies	(2,378)	(1,263)
Ending balance – September 30	$ (141,208)	$ (84,628)

XML

Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Equity [Abstract]
Net unrealized loss on available-for-sale securities, net of income taxes	$ (457)	$ (116)	$ (1,614)	$ (274)
Net unrealized gain on interest rate swaps, net of income taxes	2,647	281	6,218	1,359
Foreign currency translation	(11)	(6)	(20)	(14)
Total other comprehensive income	2,179	159	4,584	1,071
Unrealized loss on available-for-sale securities, income tax expense (benefit)	(171)	(44)	(604)	(103)
Unrealized gain on interest rate swaps, income tax expense	$ 863	$ 90	$ 2,041	$ 436

XML

Employee Stock Plans - Additional Information (Details) - shares shares in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2019
Performance share units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation arrangement by share-based payment award, remaining contractual term	3 years
Performance share units, vesting period	3 years
Achievement of an earnings per share target	70.00%
Achievement of total growth in revenue	30.00%
Performance share units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of initial grant	200.00%
2019 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum stock based compensation awards granted under the plan (in shares)		3.1

XML

Employee Stock Plans - Schedule of Stock-Based Compensation Awards (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-Based Payment Arrangement [Abstract]
Stock options	$ 0	$ 581	$ 248	$ 1,114
Restricted stock units and awards	1,188	1,388	4,015	4,214
Performance share units	4,371	936	7,724	3,031
Total stock-based compensation expense	$ 5,559	$ 2,905	$ 11,987	$ 8,359

XML

Employee Stock Plans - Schedule of Stock Options Award Activity (Details) - $ / shares shares in Thousands	9 Months Ended
	Sep. 30, 2022
Stock Option Activity
Outstanding at beginning of period (in shares)	1,223
Granted (in shares)	0
Exercised or released (in shares)	(541)
Expired or canceled (in shares)	0
Outstanding at end of period (in shares)	682
Exercisable at end of period (in shares)	682
Stock Option Weighted Average Exercise Price Per Share
Outstanding at beginning of period (in dollars per share)	$ 17.71
Granted (in dollars per share)	0
Exercised or released (in dollars per share)	14.78
Expired or canceled (in dollars per share)	0
Outstanding at end of period (in dollars per share)	20.04
Exercisable at end of period (in dollars per share)	$ 20.04

XML

Employee Stock Plans - Schedule of Restricted Stock Units and Awards Activity (Details) shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Restricted Stock Units and Awards Activity
Exercisable at end of period (in shares) | shares	682
Restricted Stock Units and Awards Weighted Average Grant Date Fair Value
Exercisable at end of period (in dollars per share) | $ / shares	$ 20.04
Restricted Stock Units and Awards
Restricted Stock Units and Awards Activity
Outstanding at beginning of period (in shares) | shares	389
Granted (in shares) | shares	130
Exercised or released (in shares) | shares	(238)
Expired or canceled (in shares) | shares	(4)
Outstanding at end of period (in shares) | shares	277
Restricted Stock Units and Awards Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 25.07
Granted (in dollars per share) | $ / shares	38.53
Exercised or released (in dollars per share) | $ / shares	23.47
Expired or canceled (in dollars per share) | $ / shares	34.04
Outstanding at end of period (in dollars per share) | $ / shares	$ 32.62
Performance share units
Restricted Stock Units and Awards Activity
Outstanding at beginning of period (in shares) | shares	473
Granted (in shares) | shares	103
Exercised or released (in shares) | shares	(211)
Expired or canceled (in shares) | shares	(5)
Outstanding at end of period (in shares) | shares	442
Restricted Stock Units and Awards Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 23.64
Granted (in dollars per share) | $ / shares	38.15
Exercised or released (in dollars per share) | $ / shares	19.82
Expired or canceled (in dollars per share) | $ / shares	33.21
Outstanding at end of period (in dollars per share) | $ / shares	$ 29.12

XML

Employee Stock Plans - Schedule of Performance Share Units Award Activity (Details) - Performance share units shares in Thousands	9 Months Ended
	Sep. 30, 2022 $ / shares shares
Performance Share Units Award Activity
Outstanding at beginning of period (in shares) | shares	473
Granted (in shares) | shares	103
Vested (in shares) | shares	(211)
Canceled (in shares) | shares	(5)
Adjustments for performance results (in shares) | shares	82
Outstanding at end of period (in shares) | shares	442
Performance Share Units Award Weighted Average Grant Date Fair Value
Outstanding at beginning of period (in dollars per share) | $ / shares	$ 23.64
Granted (in dollars per share) | $ / shares	38.15
Vested (in dollars per share) | $ / shares	19.82
Adjustments for performance results (in dollars per share) | $ / shares	25.75
Canceled (in dollars per share) | $ / shares	33.21
Outstanding at end of period (in dollars per share) | $ / shares	$ 29.12

XML

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Income from continuing operations	$ 27,474	$ 21,695	$ 116,865	$ 80,524
Basic
Weighted average common shares outstanding (in shares)	51,457,000	52,425,000	51,827,000	52,885,000
Diluted
Stock options (in shares)	434,000	609,000	523,000	692,000
Restricted stock units and awards (in shares)	118,000	155,000	141,000	182,000
Performance share units (in shares)	205,000	0	205,000	0
Contingent shares (in shares)	24,000	37,000	24,000	37,000
Diluted weighted average common shares outstanding (in shares)	52,238,000	53,226,000	52,720,000	53,796,000
Basic earnings per share from continuing operations (in dollars per share)	$ 0.53	$ 0.41	$ 2.25	$ 1.52
Diluted earnings per share from continuing operations (in dollars per share)	$ 0.53	$ 0.41	$ 2.22	$ 1.50
Share-based payment arrangement
Dilutive Securities Included And Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Share based awards excluded from the calculation of diluted earnings per share (in shares)	0	44,000	72,000	106,000
Performance share units
Dilutive Securities Included And Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Share based awards excluded from the calculation of diluted earnings per share (in shares)	237,000	447,000	237,000	447,000

XML

Business Combinations - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) business	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) business	Sep. 30, 2021 USD ($) business
Business Acquisition, Contingent Consideration [Line Items]
Annual revenue			$ 154,500,000
Transaction and integration related costs			9,300,000
Proceeds from sales of divested operations			$ 2,906,000	$ 9,785,000
Gain from the sale of its individual wealth management business		$ 0		$ 0
Benefits and Insurance Services
Business Acquisition, Contingent Consideration [Line Items]
Number of businesses sold | business	1		1	1
Proceeds from sales of divested operations	$ 2,500,000		$ 2,500,000	$ 9,700,000
Gain from the sale of its individual wealth management business	$ 2,400,000		$ 2,400,000	$ 6,400,000
Client list
Business Acquisition, Contingent Consideration [Line Items]
Acquired finite-lived intangible assets, useful life			10 years
Other intangibles
Business Acquisition, Contingent Consideration [Line Items]
Acquired finite-lived intangible assets, useful life			3 years

XML

Business Combinations - Aggregated Consideration And Preliminary Purchase Price Allocation (Details) - Series of Individually Immaterial Business Acquisitions - USD ($) shares in Thousands, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Business Acquisition, Contingent Consideration [Line Items]
Common stock issued (in shares)	42	207
Common stock value	$ 1,668	$ 6,940
Cash paid	79,141	66,051
Recorded contingent consideration	74,199	38,148
Total recorded purchase price	155,008	111,139
Accounts receivable acquired	20,429	13,125
Fixed assets acquired	1,933	1,473
Identifiable intangible assets acquired	53,400	40,753
Operating lease right-of-use asset acquired	49,291	17,814
Other assets acquired	1,693	1,316
Operating lease liability acquired - current	(5,860)	(2,785)
Other current liabilities acquired	(1,594)	(5,735)
Operating lease liability acquired - non-current	(43,431)	(15,029)
Goodwill	79,147	60,207
Total net assets acquired	155,008	111,139
Maximum potential contingent consideration	$ 77,075	$ 40,126

XML

Business Combinations - Segment Allocation (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 30, 2021
Financial Services
Business Combination Segment Allocation [Line Items]
Goodwill	$ 79,147	$ 58,409
Total	132,547	97,826
Financial Services | Client list
Business Combination Segment Allocation [Line Items]
Intangibles	53,400	38,580
Financial Services | Other intangibles
Business Combination Segment Allocation [Line Items]
Intangibles	0	837
Benefits and Insurance Services
Business Combination Segment Allocation [Line Items]
Goodwill	0	1,798
Total	0	3,134
Benefits and Insurance Services | Client list
Business Combination Segment Allocation [Line Items]
Intangibles	0	1,290
Benefits and Insurance Services | Other intangibles
Business Combination Segment Allocation [Line Items]
Intangibles	$ 0	$ 46

XML

Business Combinations - Changes in Contingent Purchase Price Consideration (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Net expense	$ 440	$ 846	$ 1,917	$ 1,599
Cash settlement paid	$ 4,167	$ 0	$ 12,289	$ 7,584
Shares issued (number)	26	13	45	66

XML

Segment Disclosures - Additional Information (Details)	9 Months Ended
	Sep. 30, 2022 segment
Segment Reporting [Abstract]
Number of business units of the company	3

XML

Segment Disclosures - Summary of Disaggregation of Revenue by Source (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 363,262	$ 282,719	$ 1,116,936	$ 862,097
Financial Services
Disaggregation of Revenue [Line Items]
Revenue	259,998	187,232	808,052	577,970
Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	92,067	85,797	276,261	255,656
National Practices
Disaggregation of Revenue [Line Items]
Revenue	11,197	9,690	32,623	28,471
Accounting, tax, advisory and consulting
Disaggregation of Revenue [Line Items]
Revenue	259,998	187,232	808,052	577,970
Accounting, tax, advisory and consulting | Financial Services
Disaggregation of Revenue [Line Items]
Revenue	259,998	187,232	808,052	577,970
Accounting, tax, advisory and consulting | Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Accounting, tax, advisory and consulting | National Practices
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Core benefits and insurance services
Disaggregation of Revenue [Line Items]
Revenue	88,364	83,009	264,666	246,367
Core benefits and insurance services | Financial Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Core benefits and insurance services | Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	88,364	83,009	264,666	246,367
Core benefits and insurance services | National Practices
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Non-core benefits and insurance services
Disaggregation of Revenue [Line Items]
Revenue	3,703	2,788	11,595	9,289
Non-core benefits and insurance services | Financial Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Non-core benefits and insurance services | Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	3,703	2,788	11,595	9,289
Non-core benefits and insurance services | National Practices
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Managed networking, hardware services
Disaggregation of Revenue [Line Items]
Revenue	8,514	7,088	24,768	20,952
Managed networking, hardware services | Financial Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Managed networking, hardware services | Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
Managed networking, hardware services | National Practices
Disaggregation of Revenue [Line Items]
Revenue	8,514	7,088	24,768	20,952
National practices consulting
Disaggregation of Revenue [Line Items]
Revenue	2,683	2,602	7,855	7,519
National practices consulting | Financial Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
National practices consulting | Benefits and Insurance Services
Disaggregation of Revenue [Line Items]
Revenue	0	0	0	0
National practices consulting | National Practices
Disaggregation of Revenue [Line Items]
Revenue	$ 2,683	$ 2,602	$ 7,855	$ 7,519

XML

Segment Disclosures - Summary of Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Information [Line Items]
Revenue	$ 363,262	$ 282,719	$ 1,116,936	$ 862,097
Operating expenses (income)	306,017	238,328	886,052	699,233
Gross margin	57,245	44,391	230,884	162,864
Corporate general and administrative expenses	15,893	13,035	43,128	41,334
Legal settlement, net	0	0	0	30,468
Operating income	41,352	31,356	187,756	91,062
Other income (expense):
Interest expense	(2,305)	(1,016)	(5,209)	(2,852)
Gain on sale of operations, net	176	0	311	6,385
Other income (expense), net	(2,618)	(1,133)	(24,919)	12,029
Total other (expense) income, net	(4,747)	(2,149)	(29,817)	15,562
Income from continuing operations before income tax expense	36,605	29,207	157,939	106,624
Financial Services
Segment Reporting Information [Line Items]
Revenue	259,998	187,232	808,052	577,970
Benefits and Insurance Services
Segment Reporting Information [Line Items]
Revenue	92,067	85,797	276,261	255,656
National Practices
Segment Reporting Information [Line Items]
Revenue	11,197	9,690	32,623	28,471
Operating segments | Financial Services
Segment Reporting Information [Line Items]
Revenue	259,998	187,232	808,052	577,970
Operating expenses (income)	220,337	156,178	639,780	448,844
Gross margin	39,661	31,054	168,272	129,126
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net				0
Operating income	39,661	31,054	168,272	129,126
Other income (expense):
Interest expense	0	0	0	0
Gain on sale of operations, net	176		311	0
Other income (expense), net	103	18	274	310
Total other (expense) income, net	279	18	585	310
Income from continuing operations before income tax expense	39,940	31,072	168,857	129,436
Operating segments | Benefits and Insurance Services
Segment Reporting Information [Line Items]
Revenue	92,067	85,797	276,261	255,656
Operating expenses (income)	73,321	69,039	220,998	203,748
Gross margin	18,746	16,758	55,263	51,908
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net				0
Operating income	18,746	16,758	55,263	51,908
Other income (expense):
Interest expense	(4)	0	(5)	0
Gain on sale of operations, net	0		0	6,385
Other income (expense), net	2,402	(9)	2,366	863
Total other (expense) income, net	2,398	(9)	2,361	7,248
Income from continuing operations before income tax expense	21,144	16,749	57,624	59,156
Operating segments | National Practices
Segment Reporting Information [Line Items]
Revenue	11,197	9,690	32,623	28,471
Operating expenses (income)	9,743	8,514	29,218	25,542
Gross margin	1,454	1,176	3,405	2,929
Corporate general and administrative expenses	0	0	0	0
Legal settlement, net				0
Operating income	1,454	1,176	3,405	2,929
Other income (expense):
Interest expense	0	0	0	0
Gain on sale of operations, net	0		0	0
Other income (expense), net	8	1	9	1
Total other (expense) income, net	8	1	9	1
Income from continuing operations before income tax expense	1,462	1,177	3,414	2,930
Corporate and Other
Segment Reporting Information [Line Items]
Revenue	0	0	0	0
Operating expenses (income)	2,616	4,597	(3,944)	21,099
Gross margin	(2,616)	(4,597)	3,944	(21,099)
Corporate general and administrative expenses	15,893	13,035	43,128	41,334
Legal settlement, net				30,468
Operating income	(18,509)	(17,632)	(39,184)	(92,901)
Other income (expense):
Interest expense	(2,301)	(1,016)	(5,204)	(2,852)
Gain on sale of operations, net	0		0	0
Other income (expense), net	(5,131)	(1,143)	(27,568)	10,855
Total other (expense) income, net	(7,432)	(2,159)	(32,772)	8,003
Income from continuing operations before income tax expense	$ (25,941)	$ (19,791)	$ (71,956)	$ (84,898)

XML

Subsequent Events (Details) - USD ($) $ in Thousands, shares in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Oct. 26, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Subsequent Event [Line Items]
Share repurchases, value		$ 32,422	$ 21,445	$ 67,976	$ 84,883
Subsequent Event
Subsequent Event [Line Items]
Share repurchases (in shares)	0.4
Share repurchases, value	$ 18,000